Professor Andrew Abell

Professor

School of Physics, Chemistry and Earth Sciences

Faculty of Sciences, Engineering and Technology

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Andrew graduated from the University of Adelaide with BSc(Hon) and PhD and then undertook a postdoctoral fellowship at the University of Cambridge. He held a professorship at the University of Canterbury before returning to the University of Adelaide in 2007, where he is currently Professor of Chemistry and node director of the ARC Centre of Excellence for Nanoscale Biophotonics. His research interests are concerned with understanding the fundamental link between the chemical structure and shape of key biological molecules and their biological function. While his work is very much driven by fundamental science, he has always had a keen interest in pursuing associated commercial opportunities. The seed for this was sown with a sabbatical leave working as a visiting scientist, consultant and senior Fulbright Fellow with SmithKline Beecham (now GSK) in Philadelphia. In Adelaide he co-founded an Adelaide-based company (Calpain Therapeutics) to develop macrocyclic protease inhibitors as a potential treatment for cataract and other conditions. Past member of ARC College of Experts and Head of School of Chemistry and Physics at the University of Adelaide and also recent recipient of the Royal Australian Chemical Institute Adrien Albert Prize and the Alexander R. Matzuk Prize and Lecture in Drug Discovery (Baylor College of Medicine, Houston).

My Research
Career
Publications
Grants and Funding
Teaching
Supervision
Professional Activities
Contact

PROFESSOR ANDREW ABELL

The focus of our extended group is concerned with the design, synthesis, and exploitation of small molecule enzyme inhibitors and mimics of key biological compounds. These compounds provide a basis of new therapeutics for the treatment of cancer and other diseases, as well as probes to study key metabolic processes such as electron transfer. They can also be attached to surfaces to provide functional materials and biosensors.

Please see our Group webpage: https://sciences.adelaide.edu.au/physical-sciences/research/chemistry-research/the-abell-group

Please also see the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP): http://cnbp.org.au/

PhD, University of Adelaide 1985
Post-doctoral research fellowship, Cambridge, UK 1985/6
Lecturer in Chemistry University of Canterbury 1987/94
Consultant, SmithKline Beecham Pharmaceuticals, USA 1993/4
Senior Lecturer in Chemistry, University of Canterbury 1994/9
Director Canterbury Biomedical Research Centre 1999/02
Associate Professor in Chemistry, University of Canterbury 1999/01
Professor in Chemistry, University of Canterbury 2001/7
Adjunct Professor of Chemistry, University of Canterbury 2007-
Professor in Chemistry, University of Adelaide 2007-
Adjunct Professor of Chemistry, Lincoln University 2009-
Head School of Chemistry and Physics, University of Adelaide 2013/4
Adelaide Node Director Centre for Nanoscale BioPhotonics 2014-

DO YOU WANT TO JOIN OUR GROUP ?

PhD Scholarships

University scholarships for Australian students are known as Australian Postgraduate Awards (APA). These scholarships are awarded on the basis of academic merit and in designated areas of research strength within the University. The University also offers a range of Scholarships for international students.

Further information on PhD scholarships can be found at: http://www.adelaide.edu.au/scholarships/

Postdoctoral Positions

Postdoctoral positions arise from time to time, so if you're interested please get in touch and we'll get back to you ASAP.

For general postdoctoral scholarships see: Australian Research Council (ARC) and https://www.nhmrc.gov.au/grants-funding
China - http://www.csc.edu.cn
Germany - http://www.daad.de
USA - http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5179&org=OISE&from=fund

PROFESSOR ANDREW ABELL

1. CAREER OVERVIEW

My tertiary education began at the University of Adelaide where I completed a BSc with Honours (1^st class, 1982) in chemistry and biochemistry, and a PhD on the chemistry and biochemistry of terpenes (1985). This was followed by a two-year postdoctoral fellowship at Cambridge to work with Professor Sir Alan Battersby on some mechanistic problems in the biosynthesis of vitamin B₁₂ and related pigments. My time at Cambridge provided insights into the process of researching a multidisciplinary problem of considerable breadth and depth. This experience greatly expanded my skills in synthesis, protein science, enzymology, and the supervision of undergraduate and postgraduate students through my association with Pembroke College. At this time it became clear to me that my future was in academia, and with this in mind I accepted a lectureship at the University of Canterbury in 1987.

I quickly established an independent research program at Canterbury working on chemical problems of biological importance, particularly in the area of the design, synthesis and testing of inhibitors of serine proteases. My research group grew in size and stature as I branched into other areas of biological chemistry. One project on the inhibition of HIV protease proved significant for my future career path. We developed an innovative approach to the inhibition of this enzyme and I presented the results of this work at the Royal Australian Institute of Chemistry (RACI) 9th National Conference on Medicinal and Agricultural Chemistry (Melbourne). This attracted the attention of Dr Brian Metcalfe, the then head of medicinal chemistry at SmithKline Beecham (SKB) Pharmaceuticals, Philadelphia, USA (now GSK). I was later offered, and accepted, a sabbatical position to work with SKB in Philadelphia as a visiting scientist, consultant and senior Fulbright scholar for 12 months (1993-4). During this time I was exposed to the workings of a major international pharmaceutical company in what was an ‘eye opening’ experience.

I worked on a number of problems of medicinal importance at SKB, and in the process gained experience in all aspects of drug design and development from project inception, through to synthesis, in vitro and in vivo testing, patent protection, commercialization, management, and large-scale production. My work was concerned with the development of a treatment for conditions associated with an over activity of steroid 5alpha-reductase. This enzyme metabolises testosterone into the more potent androgen, dihydrotestosterone, elevated levels of which are linked to benign prostatic hyperplasia and male pattern baldness. The extended project involved collaboration between chemists, enzymologists and pharmacologists and resulted in the pioneering and development of potent non-steroidal and steroidal inhibitors of the two isozymes of this enzyme. A number of publications and a patent resulted from this work (Abell, A.D., Holt, D.A. International Application No. PCT/US95/04599, 1995) and the research program ultimately released a pharmaceutical, dutasteride. My time in the USA was greatly enhanced by my Fulbright experience, which provided insights into the workings of the USA at the time of the election of Bill Clinton as president. On returning to Canterbury, I continued to work on the steroid reductase problem and in the process developed expertise and international standing in this, and other areas of bioorganic research. At this time I was awarded the New Zealand Institute of Chemistry Easterfield medal. I remain a recognised leader in the area of non-steroidal inhibitors of steroid 5a-reductase.

A good deal of my research efforts now focuses on the design, synthesis and exploitation of small molecule inhibitors and probes of proteases and other biologically important proteins as evidenced in my publication list. This work has advanced a number of bioorganic and surface science-based projects supported by significant external research funding of >$50 million in last 10 years. This funding includes NZ FiRST (equivalent to ARC Linkage), 5 Royal Society of New Zealand Marsden grants (equivalent to ARC DP) and since arriving in Adelaide in 2007; 15 Australian Research Council grants (including ARC Centre of Excellence), three NHMRC grants, as well as funding from commercial sources, Cancer CRC, and medical organisations (see later for detail). In the process I have developed important links with industry, developed and participated in NZ Research Centres of Excellence, and established and nurtured a major collaborative research group located in Adelaide and New Zealand. In late 2011 I co-establishing a company (Calpain Therapeutics) in Adelaide to begin to exploit some of our research. We have also recently developed a potentially new first in class antibiotic based on the inhibition of Biotin Protein Ligase. In 2012 I was awarded the Adrien Albert Prize. This is the premier award of the Division of Biomolecular Chemistry of the Royal Australian Chemical Institute (RACI) and is given for sustained, outstanding research in the field of medicinal or agricultural chemistry, related to biomolecular chemistry. I was also the recipient of the Alexander R. Matzuk Prize and Lecture in Drug Discovery, (Dec 2013). This international prize was developed with support from the Department of Pathology & Immunology at Baylor College of Medicine, the Burroughs Wellcome Fund, and the Matzuk and Zechiedrich families. I am also currently the Adelaide node leader of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/), a past head of School of Chemistry and Physics (Uni of Adelaide) and recently co-established a USA-based company - ImmuniLogic.

I have supervised in excess of 80 PhD students and 50 post-doctoral fellows in the last 20 years alone, with many now occupying influential academic and industrial positions around the globe. I am pleased to say that I have a 100% completion rate on student supervisions and have >250 career supervisions. In recognition of my standing and achievements I was promoted to full Professor at the University of Canterbury in 2001. In 2007, I was offered (by the Vice Chancellor, Prof James McWha) and accepted a tenured Professorship at the University of Adelaide. I was also offered a chair of Oenology at the University of Adelaide and a Professorship at the University of South Australia, but these positions were declined in favour of my current appointment. I retain adjunct Professorships at the University of Canterbury and Lincoln University, was appointed to the ARC College of Experts, and I am a past Head of School of Chemistry and Physics at the University of Adelaide. I also served three terms an elected member of the University of Adelaide Council and as an Australian Fulbright Ambassador.

2. RESEARCH LEADERSHIP AND STANDING

My international research profile has resulted in membership of overseas delegations, committees and collaborations (see later for detail), numerous invited and in-person plenary lectures; most recently RACI conventions (Brisbane and Wollongong, 2022), Symposium on Electronic and Coupled Transport in Biology, Boston Fall MRS meeting (Boston, 2018), RACI Medicinal Chemistry and Chemical Biology Conference (Brisbane, 2018), RACI Organic Divisional Meeting (Perth, 2018), University of Strasbourg (France 2017), USA Air force Life Sciences Program Review (Dayton Ohio), the Queenstown Molecular Biology Meeting (Shanghai), Alexander R. Matzuk Lecture in Drug Discovery (Baylor College, Houston), RACI Adrien Albert address (Leura, NSW), RACI Biomolecular division conference (Torquay) and ‘Calpain FASEB Summer Research Conference’ Carefree, Arizona; ‘International Symposium on Olefin Metathesis’, Pasadena USA, as organised by Professor Grubbs the joint 2005 Nobel Laureate for work on metathesis; ‘surface attachment of peptides and peptidomimetics’. I am a member of editorial and advisory boards (e.g. Governing Board of NZ Chemical Genetics consortium; Editorial board of ‘Protein and Peptide Letters’, ‘Medicinal Chemistry Reviews’, and ‘Mini Reviews in Medicinal Chemistry’ and ‘Perspectives in Medicinal Chemistry, Asian Chem Letters, and others), secondment to industry, and invitations to apply for influential chairs around the globe. I have also organized a number of international meetings, most notably the Pacifichem Heterocyclics Symposium Hawaii; Chairperson of the 2003 NZIC convention; 5^th and 6^th International Peptide Conferences. Standing in my field is apparent with my appointment to the Australian Research Council (ARC) College of Experts (2011-) and a number of awards and honours as detailed in my accompanying CV. In addition to these activities I have been employed as a visiting scientist and consultant by SmithKline Beecham Pharmaceuticals (USA) and by Eli Lilly and Biogen USA Pharmaceuticals (USA) as an expert witness in international court cases concerned with patent infringement.

In 2004 co-initiated collaboration between the University of Canterbury, Lincoln University and Douglas Pharmaceuticals, to design and develop a pharmaceutical-based treatment for cataract based on the inhibition of calpain. Our extended team designed, developed, and tested an efficacious lead structure, however with my move to Adelaide in 2007 the project somewhat stagnated. With this realisation, Dr Tim Lovell (BioInnovationSA, Adelaide) and I established an Adelaide-based company (Calpain Therapeutics: http://calpaintherapeutics.com/) to commercialise the lead structure and to take advantage of the associated opportunity. Calpain Therapeutics was named the 2011 winner of The University of Queensland Business School's Enterprize competition and it has subsequently received considerable media attention. The wider aspects of this project currently account for approximately one third of my research effort, with significant external funding since its inception to support a team of researchers at the University of Canterbury, Lincoln, Douglas and now the University of Adelaide. During the course of the project we have developed and established expertise in computer-based inhibitor design, synthesis, drug formulation, delivery, and in vitro and in vivo testing. Patents have been granted and we successfully negotiated transfer and future licensing of the most important IP from Adelaide to Calpain Therapeutics. The project has identified a number of new and particularly potent, peptidomimetic-based compounds that show excellent anti-cataract activity in vitro, in lens culture, and also in in vivo-based animal trials. I significant amount of my current time is spent coordinating and balancing these activities, with academic and industrial partners and business interests. On moving to Adelaide, I extended this research into the new areas of traumatic brain injury, stroke and the inhibition of the proteasome and cathepsins as potential treatments for some cancers; and also a fundamental study into the processes of electron transfer with applications in molecular electronics. This significant endeavour has provided invaluable experience in coordinating and balancing fundamental research, involving a number of disciplines, with commercial interests and their associated demands.

A good deal of my other current research time is spent on research projects at the interface of chemistry, biochemistry and surface science. Projects include the development of inhibitors of the shikimate pathway as potential herbicides and antibacterial agents (collaboration with the University of Cambridge), the immobilization of peptides and peptidomimetics on surfaces as a basis for new functional materials to study electron transport at the most fundamental level, and biosensors in collaboration with the Institute for Photonics and Advanced Sensing (IPAS, see http://www.adelaide.edu.au/ipas/) and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/) (Marsden and ARC funded), the control of peptide and protein conformation through stereoelectronic effects (ARC funded), and recently the design and synthesis of inhibitors of Biotin Protein Ligase (BPL) as new antibacterial agents (NHMRC, CAS and private funding). This last project has already yielded a new class of inhibitor of Staphylococcus aureus that shows significant activity and promise against clinical strains of these bacteria and again efforts are underway to commercialise the outcomes. A number of high-profile publications have recently been accepted and are in preparation based on this project.

A particularly important theme in much of our work has been the development of olefin metathesis and more recently ‘click’ chemistry for the preparation and surface immobilisation of peptide like structures. Much of this work began with our publication of an invited review [Ring-closing Metathesis of nitrogen-containing compounds: applications to heterocycles, alkaloids and peptidomimetics; A. J. Phillips and A. D. Abell, Aldrichimica Acta, 1999, 32(3), 75-89]. This land-mark paper was one of the first to propose the importance of metathesis chemistry to the area of peptides and peptidomimetics, and it continues to be very well cited (>350 citations to date). Our metathesis work also offers significant potential for surface attachment studies, and for conjugating biomolecules onto active ligands and macrostructures to access important immunoconjugates, peptide-sugars, and biosensors. In order to fully exploit this we need access to metathesis catalysts that are active in aqueous conditions. Collaborative ARC-funded research was undertaken with the GKSS in Germany and Professor Bob Grubbs (2005 joint Nobel laureate for metathesis) to extend metathesis to an aqueous environment. Some of this work was present in an invited lecture at the ‘International Symposium on olefin metathesis’, Pasadena USA and we recently published a number of papers on this topic. A number of ARC funded research project concerned with the design and synthesis of peptide-like structures constrained into a beta-strand or helical geometry have also been progressed through collaboration with Professor Seebach at the ETH.

Since moving to Adelaide in 2007 I have grown a significant research group with postdoctoral fellows from Germany (DAAD funded), Switzerland (ARC international fellow), Belgium, China, Denmark, New Zealand, USA, India, Singapore, Spain, and Australia; as well as more than 70 PhD students and 50 honours students. Significant new research is being undertaken through collaboration with Adjunct Professor John Wallace of the School of Molecular and Biomedical Science, Professor Irene Hudson (now University of Newcastle and RMIT), Monash University, RMIT, Macquarie University, Chinese Academy of Sciences Beijing, ETH, Bonn, GKSS, CalTech, and with Professor Tanya Monro through the establishment and growth of the Institute for Photonics and the Advanced Sensing and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP). This major multidisciplinary research institute ($40,000,000 funding over 7 years) is directed at discovering new approaches to measure nano-scale dynamic phenomena in living system, see http://cnbp.org.au/ for detail. Our most recent and exciting work has identified a new targeted treatment for Neuropathic pain and if funded by a significant grant from the NIH (USA).

The results of my research have been published in more than 350 high impact international publications, book chapters, reviews and patents with presentations at many international meetings and institutions. I am also a past editor of two volumes of an acclaimed series on ‘Peptidomimetics’. See JACS, 1998, p10276, DOI:10.102/ja985644+ for an independent review.

3. RECENT IN PERSON PLENARY AND MAJOR INVITED LECTURES

RACI Organic and Medicinal Chemistry Conference - OMC2022 (Wollongong, 2022), RACI National Congress (Brisbane, 2022), ICOB 2019 (St Andrews, 2019), Symposium on Electronic and Coupled Transport in Biology, Boston Fall MRS meeting (Boston, 2018), RACI Medicinal Chemistry and Chemical Biology Conference (Brisbane, 2018), RACI Organic Divisional Meeting (Perth, 2018), University of Strasbourg (France 2017), USA Air force 2016 Life Sciences Program Review (Dayton Ohio, 2016), Queenstown Molecular Biology Meeting (Shanghai, March 2016), Alexander R. Matzuk Lecture in Drug Discovery (Baylor College, Houston), Royal Australian Chemical Institute Adrien Albert address (Leura, NSW), NZIC convention (Waikato); RACI Biomolecular division conference (Torquay); (Calpain FASEB Summer Research Conference (Carefree, Arizona, 2010); Royal Australian Chemical Institute Organic Conference (Hobart Australia, 2008); Southern Highlands Heterocyclic Symposium, Sydney (2008), Invited lecture to ‘International Symposium on olefin metathesis’, (Pasadena USA, 2007), Keynote lecture to ‘Drug design amongst the vines’ RACI meeting (Sydney, Dec 2006), 2005 International Chemical Congress of Pacific Basin Societies (Hawaii, 2005); 1^st Asia-Pacific International Peptide Symposium (Fukuoka, Japan, Nov 2004); 19^th Royal Australian Chemical Institute Organic Conference (Lorne Australia, Plenary lecture 2003); 5^th Australian Peptide Conference (Daydream Island, Oct 5-10, 2003); University of Otago collaboration series (2002); NZIC National Convention (Napier, 2001); 4^th Australian Peptide Conference (Lindeman Island, 2001); 2000 International Chemical Congress of Pacific Basin Societies (Hawaii, 2000). 6^th International Conference for AIDS Cancer and Related Problems (St Petersburg, Russia); New Zealand Institute of Chemistry Easterfield lecture; University of Melbourne Synthesis Symposium (Plenary lecture); Universities of Singapore, Melbourne, Sydney, RMT, Macquarie University, Monash, Newcastle, Canterbury, Lincoln, Cambridge, Edinburgh, Tokyo, Gratz, ETH, Yale, Pittsburg, ANU, Melbourne, Queensland, Wollongong, Otago

4. PROFESSIONAL SERVICE

In addition to the research and associated activities described above, I have extensive experience and interest in academic management and administration at the department, university, national and international levels. I am the current Adelaide node director of the Centre for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/), recent member of the University of Adelaide Council and past head of School of Chemistry and Physics at the University of Adelaide and head of Biochemistry at the University of Canterbury. These duties have provided me with an intimate knowledge and understanding of all levels of University administration. I was also an active member and contributor to many of major institutional committees; including academic board, university research committee, standing committee, academic promotions committee, and the foundation board of health. This last committee was charged with leading the universities expansion into health related disciplines.

I have been intimately involved in a number of other major research institutes and centres over the last 15 years. I was the founding director of a Research Centre at The University of Canterbury (1999-2001) with members from several university departments and Canterbury-based research organizations. This centre successfully attracted significant external funding and established multidisciplinary links throughout the university and the wider Canterbury region. This development, and my association with other university wide research activities, led to my involvement with Canterbury Health Laboratories and Crown Research Institutes (Government funded organizations analogous to the CSIRO). I remain a member of two New Zealand CoRE centres of excellence (The MacDiarmid Institute for Advanced Materials and Nanotechnology http://www.macdiarmid.ac.nz/ and the Maurice Wilkins Centre for molecular biodiscovery <http://www.mauricewilkinscentre.org/>), which were established to act as national centres of research excellence. On moving to Adelaide, I was involved in a successful Australian Federal Government HEEF application (2008), which received $28.8 million to help build a new centre for Photonics and Surface Science (IPAS). This building is part of a major new initiative established to create an interactive and integrated research and teaching environment of national and international significance, see http://www.adelaide.edu.au/ipas/. Much has been done to establish and develop this centre, including securing extended funding and opportunity and through the coordination of stakeholders, architects, and consultants. I now occupy the synthetic and surface science capability and laboratories in IPAS and the ARC Centre of Excellence for Nanoscale BioPhotonics, of which I am a CI and the Adelaide node leader

I have also served on numerous national and international review and granting bodies in recent times, including European Commission Marie Skłodowska Curie – Individual Fellowship (2016-22), ARC College of Experts (2011-14), European Union Funding Framework (Brussels), Australian National Health and Medical Research Council Program Grant Committee, the Royal Society of New Zealand Marsden Fund, and the Canterbury PBRF committee I have also spent time with the New Zealand Ministry of Research Science & Technology (MoRST) in Wellington. These experiences have enabled me to develop important links with major funding bodies and organizations. While at Canterbury, I was also a member of a high-level New Zealand government funded delegation that visited the Riken Institute in Japan (http://www.riken.jp/engn/) to develop joint programs of research and collaboration in the area chemical genetics. This culminated in the establishment of a NZ Chemical Genetics consortium, of which I was a member of the Governing Board.

Since arriving in Adelaide in 2007 I have also gained an intimate knowledge of the workings of the Australian Research Council (ARC), through my role on the College of experts, but also through developing successful multidisciplinary applications for LIEF, Linkage, SuperScience and discovery and Centre of Excellence funding. All this has required leadership and an ability to coordinate varied interests, expectations, and personalities across different disciplines and institutions. We have also developed significant collaborative funding opportunities through NHMRC, International Science Linkages (China), and commercial ventures as detailed elsewhere in this document. Most recently I was appointed an Australian Fulbright Ambassador and I am currently the University of Adelaide Honours Chemistry Coordinator.

Appointments

Date	Position	Institution name
2014 - ongoing	Adelaide Node Leader	Centre for Nanosale BioPhotonics (CNBP)
2013 - 2014	Head of School of Chemistry and Physics	The University of Adelaide
2011 - ongoing	Chief Scientific Advisor	Calpain Therapeutics
2007 - ongoing	Professor	University of Adelaide
2007 - ongoing	Adjunct Professor	University of Canterbury
2007 - ongoing	Adjunct Professor	Lincoln University (New Zealand)
2001 - 2007	Professor	University of Canterbury
1993 - 1994	Visiting Scientist and Fulbright Scientist	SmithKline Beecham
1985 - 1987	Postdoctoral Fellow	University of Cambridge

Awards and Achievements

Date	Type	Title	Institution Name	Country	Amount
2022	Distinction	NIH funding	University of Adelaide	United States	-
2022	Achievement	coestablished USA-based company	Immunologic	United States	-
2017	Distinction	Visiting Professorship	University of Strasbourg	France	-
2017	Honour	Visiting Professor University of Strasbourg	-	-	-
2016	Distinction	Funding Body	European Union Funding Framework	Belgium	-
2015	Award	University of Queensland (UQ) Business-School Enterprize Award	University of Queensland	Australia	-
2015	Achievement	Calpain Therapeutics, chief Acientific Officer	Calpain Therapeutics Company	Australia	-
2013	Award	Alexander R. Matzuk Prize and Lecture in Drug Discovery	-	-	-
2013	Achievement	consultancy	Minter Ellison	Australia	-
2013	Achievement	Founding member of the Institute for Photonics and Advanced Sensing	University of Adelaide	Australia	-
2012	Award	Adrien Albert Prize	-	-	-
2011	Award	The University of Queensland Business School's Enterprize	-	-	-
2010	Distinction	Adjunct Professor at the University of Canterbury Lincoln University	-	-	-
2007	Distinction	Fellow of Royal Australian Institute of Chemistry	-	-	-
2007	Honour	Adjunct Professor at the University of Canterbury	-	-	-
2004	Distinction	Elected Member of the New Zealand Centre for Molecular Biodiscovery CoRE	-	-	-
2003	Fellowship	University of Canterbury Erskine Fellowship	-	-	-
2002	Distinction	Elected member of the New Zealand MacDiarmid Institute for Advanced Materials and Nanotechnology CoRE	-	-	-
2001	Fellowship	University of Canterbury Erskine Fellowship	-	-	-
2000	Honour	Elected member of the American Chemical Society	-	-	-
2000	Distinction	American Chemical Society Member	American Chemical Society (ACS)	United States	-
1999	Distinction	University of Canterbury Academic Board	University of Canterbury	New Zealand	-
1998	Award	Royal Society of Chemistry Journals Grants for international Authors	-	-	-
1997	Invitation	Invited Editor for JAI Press, London and Connecticut	-	-	-
1995	Award	Easterfield medal	-	-	-
1995	Distinction	Fellow of New Zealand Institute of Chemistry (FNZIC)	-	-	-
1993	Award	Fulbright Fellow	-	-	-
1993	Distinction	Visiting Scientist and Consultant SmithKline Beecham Pharmaceuticals USA	SmithKline Beecham	United States	-
1985	Research Award	George Murray Scholarship	-	-	-
1981	Award	C.S.R. Chemicals Prize	-	-	-

Journals

Year	Citation
2024	Mo, W., Horsley, J. R., Li, X., Sheng, S., Jong, B., Abell, A. D., . . . Yu, J. (2024). Single-molecule Conductance and Electrochemical Measurements of Electron Transfer in β-strand Peptides. ChemElectroChem, 11(1), 9 pages. DOI
2024	Tran, H. N. Q., Tran, K. N., Gunenthiran, S., Wang, J., Law, C. S., Lim, S. Y., . . . Santos, A. (2024). Tailoring Tamm Plasmon Resonances in Dielectric Nanoporous Photonic Crystals. ACS Applied Materials and Interfaces, 16(9), 11787-11799. DOI
2024	Palasis, K. A., & Abell, A. D. (2024). Effect of indoline substitution on ring opening in 6-nitro BIPS spiropyran derivatives. Tetrahedron Letters, 138, 5 pages. DOI
2024	Gunenthiran, S., Law, C. S., Wang, J., Lim, S. Y., Abell, A. D., Alwahabi, Z. T., & Santos, A. (2024). Engineering of Solid-State Nanoporous Laser through Dendrimer-Encapsulated Fluorophores. ACS Applied Materials and Interfaces, 16(12), 15059-15072. DOI
2024	Vu, K. N., Law, C. S., Lord, C., Wang, J., Lim, S. Y., Horsley, J., . . . Santos, A. (2024). Harnessing the Intrinsic Ionic Rectification Properties of Blind-Hole Nanoporous Anodic Alumina for Osmotic Energy Generation. Advanced Functional Materials, 15 pages. DOI
2023	Salaemae, W., Thompson, A. P., Gaiser, B. I., Lee, K. J., Huxley, M. T., Sumby, C. J., . . . Wegener, K. L. (2023). Fortuitous <i>In Vitro</i> Compound Degradation Produces a Tractable Hit against <i>Mycobacterium tuberculosis</i> Dethiobiotin Synthetase: A Cautionary Tale of What Goes In Does Not Always Come Out. ACS Chemical Biology, 18(9), 1985-1992. DOI
2023	Wang, J., Law, C. S., Gunenthiran, S., Lim, S. Y., Vu, K. N., Ngo, V. T., . . . Santos, A. (2023). Understanding the Intrinsic Rectification Properties of Nanoporous Anodic Alumina by Selective Chemical Etching. ACS Applied Materials and Interfaces, 15(39), 45981-45996. DOI Scopus1
2023	Becker, R., Pederick, J. L., Dawes, E. G., Bruning, J. B., & Abell, A. D. (2023). Structure-guided design and synthesis of ATP-competitive N-acyl-substituted sulfamide D-alanine-D-alanine ligase inhibitors. Bioorganic and Medicinal Chemistry, 96, 14 pages. DOI
2023	Lim, S. Y., Law, C. S., Tran, K. N., Tran, H. N. Q., Abell, A. D., & Santos, A. (2023). Engineering Nanoporous Anodic Alumina Bilayered Interferometers for Liquid and Gas Sensing. ACS Applied Nano Materials, 6(22), 20954-20969. DOI
2023	Tran, K. N., Tran, H. N. Q., Gunenthiran, S., Wang, J., Law, C. S., Lim, S. Y., . . . Santos, A. (2023). Desorption Kinetics Profiling of Volatile Organic Compounds in Nanoporous Anodic Alumina Photonic Crystal Optical Microcavities. ACS Applied Optical Materials, 1(12), 1987-2003. DOI
2023	Vandborg, B. C., Horsfall, A. J., Pederick, J. L., Abell, A. D., & Bruning, J. B. (2023). Towards a High-Affinity Peptidomimetic Targeting Proliferating Cell Nuclear Antigen from Aspergillus fumigatus. Journal of Fungi, 9(11), 16 pages. DOI
2023	Stachura, D. L., Nguyen, S., Polyak, S. W., Jovcevski, B., Bruning, J. B., & Abell, A. D. (2023). Structural Study of Potent Triazole-Based Inhibitors of <i>Staphylococcus aureus</i> Biotin Protein Ligase. ACS Medicinal Chemistry Letters, 14(3), 285-290. DOI
2023	Salaemae, W., Thompson, A., Gaiser, B., Lee, K. J., Huxley, M., Sumby, C., . . . Wegener, K. (2023). Fortuitous<i>in vitro</i>compound degradation produces a tractable hit against<i>Mycobacterium tuberculosis</i>dethiobiotin synthetase: a cautionary tale of what goes in, does not always come out. DOI
2023	Agnew, H. N., Atack, J. M., Fernando, A. R. D., Waters, S. N., van der Linden, M., Smith, E., . . . Trappetti, C. (2023). Uncovering the link between the SpnIII restriction modification system and LuxS in Streptococcus pneumoniae meningitis isolates. Frontiers in Cellular and Infection Microbiology, 13, 1-12. DOI
2023	Frkic, R. L., Pederick, J. L., Horsfall, A. J., Jovcevski, B., Crame, E. E., Kowalczyk, W., . . . Bruning, J. B. (2023). PPARγ Corepression Involves Alternate Ligand Conformation and Inflation of H12 Ensembles. ACS Chemical Biology, 18(5), 1115-1123. DOI Scopus1
2023	Kalyvas, J. T., Marina, P. F., Stachura, D. L., Horsley, J., & Abell, A. D. (2023). Smart Wearable Patches Using Light-Controlled Activation and Delivery of Photoswitchable Antimicrobial Peptides. Chemistry, 29(46), 1-8. DOI
2023	Wang, J., Vu, K. N., Abell, A. D., Santos, A., & Law, C. S. (2023). Nanoporous anodic alumina-based iontronics: fundamentals and applications. Journal of Materials Chemistry C, 11(27), 9051-9081. DOI Scopus3
2023	Horsfall, A. J., Chav, T., Pederick, J. L., Kikhtyak, Z., Vandborg, B. C., Kowalczyk, W., . . . Bruning, J. B. (2023). Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen. Journal of Medicinal Chemistry, 66(15), 10354-10363. DOI
2023	Palasis, K., Peddie, V., Turner, D., Zhang, X., Yu, J., & Abell, A. D. (2023). Exploring Photoswitchable Binding Interactions with Small Molecule- and Peptide-Based Inhibitors of Trypsin. ChemBioChem, 24(20), e202300453-1-e202300453-14. DOI Scopus1 WoS1
2022	Thomas, J. H. L., Lui, L., Abell, A., Tieu, W., Somogyi, A. A., Bajic, J. E., & Hutchinson, M. R. (2022). Toll-Like Receptors change morphine-induced antinociception, tolerance and dependence: studies using male and female TLR and Signalling gene KO mice. Brain, Behavior, and Immunity, 102, 71-85. DOI Scopus9 WoS7 Europe PMC5
2022	Gunenthiran, S., Wang, J., Zhao, W., Law, S., Lim, S. Y., McInnes, J. A., . . . Santos, A. (2022). Lasing from Narrow Bandwidth Light-Emitting One-Dimensional Nanoporous Photonic Crystals. ACS Photonics, 9(4), 1226-1239. DOI Scopus5 WoS4
2022	Wang, J., Law, C. S., Gunenthiran, S., Tran, H. N. Q., Tran, N. K., Lim, S. Y., . . . Santos, A. (2022). Structural Engineering of the Barrier Oxide Layer of Nanoporous Anodic Alumina for Iontronic Sensing. ACS Applied Materials and Interfaces, 14(18), 21181-21197. DOI Scopus7 WoS4
2022	Horsley, J. R., Jovcevski, B., Pukala, T. L., & Abell, A. D. (2022). Designer D-peptides targeting the N-terminal region of α-synuclein to prevent parkinsonian-associated fibrilization and cytotoxicity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1870(10), 140826-1-140826-9. DOI Scopus4 WoS2 Europe PMC1
2022	Lim, S. Y., Hedrich, C., Law, C. S., Abell, A. D., Blick, R. H., Furlan, K. P., . . . Santos, A. (2022). Nanoporous Anodic Alumina Photonic Crystals for Sunlight Harvesting Applications: A Perspective. Solar RRL, 6(10), 1-32. DOI Scopus1 WoS1
2022	Gunenthiran, S., Wang, J., Que Tran, H. N., Tran, K. N., Lim, S. Y., Law, C. S., . . . Santos, A. (2022). Engineering of Solid-State Random Lasing in Nanoporous Anodic Alumina Photonic Crystals. ACS Applied Nano Materials, 5(9), 12174-12188. DOI Scopus4 WoS1
2022	Pederick, J. L., Horsfall, A. J., Jovcevski, B., Klose, J., Abell, A. D., Pukala, T. L., & Bruning, J. B. (2022). Discovery of an ʟ-amino acid ligase implicated in Staphylococcal sulfur amino acid metabolism. Journal of Biological Chemistry, 298(10), 1-16. DOI Scopus1 WoS1
2022	Stachura, D. L., Nguyen, S., Polyak, S. W., Jovcevski, B., Bruning, J. B., & Abell, A. D. (2022). A New 1,2,3-Triazole Scaffold with Improved Potency against Staphylococcus aureus Biotin Protein Ligase. ACS Infectious Diseases, 8(12), 2579-2585. DOI Scopus3 WoS2 Europe PMC1
2022	Capon, P. K., Li, J., Horsfall, A. J., Yagoub, S., Schartner, E. P., Khalid, A., . . . Abell, A. D. (2022). A silk‐based functionalization architecture for single fiber imaging and sensing. Advanced Functional Materials, 32(3), 2010713-1-2010713-11. DOI Scopus7 WoS6
2022	Tran, H. N. Q., Le, N., Le, Q. N., Law, S., Lim, S. Y., Abell, A. D., & Santos, A. (2022). Spectral Engineering of Tamm Plasmon Resonances in Dielectric Nanoporous Photonic Crystal Sensors. ACS Applied Materials and Interfaces, 14(20), 22747-22761. DOI Scopus12 WoS6 Europe PMC2
2022	Law, C. S., Wang, J., Gunenthiran, S., Lim, S. Y., Abell, A. D., Ahrens, L., . . . Voelcker, N. H. (2022). Real-time detection of per-fluoroalkyl substance (PFAS) self-assembled monolayers in nanoporous interferometers. Sensors and Actuators B: Chemical, 355, 1-10. DOI Scopus6 WoS2
2022	Staikopoulos, V., Zhang, X., Pullen, B. P., Reineck, P., Vidanapathirana, A. K., Lee, S. M., . . . Abell, A. D. (2022). Multi-coloured fluorescent sensing toolbox for selective detection of nitroxyl <i>in vitro</i> and <i>ex vivo</i>. Sensors & Diagnostics, 1(2), 280-293. DOI Scopus1 WoS1
2021	Pei, L. -Q., Horsley, J. R., Seng, J. -W., Liu, X., Yeoh, Y. Q., Yu, M. -X., . . . Jin, S. (2021). Mechanically induced switching between two discrete conductance states: a potential single-molecule variable resistor. ACS Applied Materials and Interfaces, 13(48), 57646-57653. DOI Scopus15 WoS10 Europe PMC4
2021	Lim, S. Y., Hedrich, C., Jiang, L., Law, S., Chirumamilla, M., Abell, A. D., . . . Santos, A. (2021). Harnessing Slow Light in Optoelectronically Engineered Nanoporous Photonic Crystals for Visible Light-Enhanced Photocatalysis. ACS Catalysis, 11(21), 12947-12962. DOI Scopus22 WoS20
2021	Horsley, J. R., Wang, X., Yu, J., & Abell, A. D. (2021). Exploiting conformationally gated electron transfer in self-assembled azobenzene-containing cyclic peptides using light. Electrochimica Acta, 381, 138232-1-138232-8. DOI Scopus1
2021	Horsfall, A. J., Chav, T., Bruning, J. B., & Abell, A. D. (2021). A turn-on fluorescent PCNA sensor. Bioorganic & Medicinal Chemistry Letters, 41, 128031-1-128031-6. DOI
2021	Horsfall, A. J., Vandborg, B. A., Kowalczyk, W., Chav, T., Scanlon, D. B., Abell, A. D., & Bruning, J. B. (2021). Unlocking the PIP-box: A peptide library reveals interactions that drive high affinity binding to human PCNA.. The Journal of biological chemistry, 296, 1-16. DOI Scopus8 WoS6 Europe PMC6
2021	Horsfall, A. J., McDougal, D. P., Scanlon, D. B., Bruning, J. B., & Abell, A. D. (2021). Approaches to introduce helical structure in cysteine-containing peptides with a bimane group. Chembiochem, 22(17), 2711-2720. DOI Scopus3 WoS3 Europe PMC1
2021	Capon, P. K., Horsfall, A. J., Li, J., Schartner, E. P., Khalid, A., Purdey, M. S., . . . Abell, A. D. (2021). Protein detection enabled using functionalised silk-binding peptides on a silk-coated optical fibre. RSC Advances, 11(36), 22334-22342. DOI Scopus2 WoS1
2021	Horsfall, A. J., Vandborg, B., Kikhtyak, Z., Scanlon, D. B., Tilley, W. D., Hickey, T. E., . . . Abell, A. D. (2021). A cell permeable bimane-constrained PCNA-interacting peptide. RSC Chemical Biology, 2(5), 1499-1508. DOI Scopus5 WoS3 Europe PMC2
2021	Avery, T., Li, J., Turner, D., Cherry, F., Ur Rasheed, M., Aguilar, C., . . . Abell, A. (2021). Drug targeting to sites of oxidative stress using the Baeyer-Villiger reaction. DOI
2021	Schumann, N. C., Lee, K. J., Thompson, A. P., Salaemae, W., Pederick, J. L., Avery, T., . . . Abell, A. D. (2021). Inhibition of Mycobacterium tuberculosis dethiobiotin synthase (MtDTBS): toward next-generation antituberculosis agents. ACS Chemical Biology, 16(11), 2339-2347. DOI Scopus5 WoS3 Europe PMC3
2021	Horsfall, A. J., & Abell, A. D. (2021). An inherently fluorescent peptide constraint to define secondary structure: moving away from auxiliary tags. Australian Journal of Chemistry, 74(9), 686-687. DOI Scopus1
2021	Palasis, K. A., Lokman, N. A., Quirk, B. C., Adwal, A., Scolaro, L., Huang, W., . . . Abell, A. D. (2021). Optical fibre-enabled photoswitching for localised activation of an anti-cancer therapeutic drug. International Journal of Molecular Sciences, 22(19), 10844-1-10844-10. DOI Scopus3 WoS3 Europe PMC1
2021	Liu, L., Lim, S. Y., Law, C. S., Acosta, L. K., Jin, B., Abell, A. D., . . . Santos, A. (2021). Optical engineering of nanoporous photonic crystals by Gaussian-like pulse anodization. Microporous and Mesoporous Materials, 312, 110770-1-110770-13. DOI Scopus7 WoS7
2021	Capon, P. K., Avery, T. D., Purdey, M. S., & Abell, A. D. (2021). An improved synthesis of 4-aminobutanenitrile from 4-azidobutanenitrile and comments on room temperature stability. Synthetic Communications, 51(3), 428-436. DOI Scopus1
2021	Vidanapathirana, A. K., Psaltis, P. J., Bursill, C. A., Abell, A. D., & Nicholls, S. J. (2021). Cardiovascular bioimaging of nitric oxide: achievements, challenges, and the future. Medicinal research reviews, 41(1), 435-463. DOI Scopus22 WoS16 Europe PMC7
2021	Hoogendoorn, A., Avery, T. D., Li, J., Bursill, C., Abell, A., & Grace, P. M. (2021). Emerging therapeutic applications for fumarates. Trends in Pharmacological Sciences, 42(4), 239-254. DOI Scopus14 WoS12 Europe PMC9
2021	Acosta, L. K., Law, S., Lim, S. Y., Abell, A. D., Marsal, L. F., & Santos, A. (2021). Role of spectral resonance features and surface chemistry in the optical sensitivity of light-confining nanoporous photonic crystals. ACS Applied Materials and Interfaces, 13(12), 14394-14406. DOI Scopus8 WoS6 Europe PMC2
2020	McLennan, H. J., Sutton-McDowall, M. L., Heng, S., Abell, A. D., & Thompson, J. G. (2020). Time-lapse confocal imaging-induced calcium ion discharge from the cumulus-oocyte complex at the time of cattle oocyte activation. Reproduction, Fertility and Development, 32(14), 1223-1238. DOI Scopus1 WoS1 Europe PMC1
2020	Liu, L., Lim, S. Y., Law, C. S., Jin, B., Abell, A. D., Ni, G., & Santos, A. (2020). Engineering of broadband nanoporous semiconductor photonic crystals for visible-light-driven photocatalysis. ACS Applied Materials and Interfaces, 12(52), 57079-57092. DOI Scopus16 WoS15 Europe PMC1
2020	Lim, S. Y., Law, C. S., Jiang, L., Acosta, L. K., Bachhuka, A., Marsal, L. F., . . . Santos, A. (2020). Enhancing forbidden light propagation in nanoporous anodic alumina gradient-index filters by alcohol additives. ACS Applied Nano Materials, 3(12), 12115-12129. DOI Scopus7 WoS6
2020	Chen, X., Yeoh, Y. Q., He, Y., Zhou, C., Horsley, J. R., Abell, A. D., . . . Guo, X. (2020). Unravelling Structural Dynamics within a Photoswitchable Single Peptide: A Step Towards Multimodal Bioinspired Nanodevices. Angewandte Chemie, 132(50), 22743-22751. DOI
2020	Yu, J., Horsley, J. R., & Abell, A. D. (2020). Unravelling electron transfer in peptide-cation complexes: a model for mimicking redox centres in proteins. Physical Chemistry Chemical Physics, 22(16), 8409-8417. DOI Scopus5 WoS5 Europe PMC1
2020	Yeoh, Y. Q., Horsley, J. R., Polyak, S. W., & Abell, A. D. (2020). A hypoxia-activated antibacterial prodrug. Bioorganic and Medicinal Chemistry Letters, 30(11), 127140-1-127140-3. DOI Scopus2 WoS2 Europe PMC1
2020	Hayes, A. J., Satiaputra, J., Sternicki, L. M., Paparella, A. S., Feng, Z., Lee, K. J., . . . Polyak, S. W. (2020). Advanced resistance studies identify two discrete mechanisms in staphylococcus aureus to overcome antibacterial compounds that target biotin protein ligase. Antibiotics, 9(4), 1-20. DOI Scopus3 WoS3
2020	Horsley, J. R., Jovcevski, B., Wegener, K. L., Yu, J., Pukala, T. L., & Abell, A. (2020). Rationally Designed Peptide-Based Inhibitor of Aβ42 Fibril Formation and Toxicity: A Potential Therapeutic Strategy for Alzheimer's Disease.. Biochem J, 477(11), 2039-2054. DOI Scopus18 WoS30 Europe PMC20
2020	Yan, F., Chen, F., Wu, X. -H., Luo, J., Zhou, X. S., Horsley, J. R., . . . Mao, B. -W. (2020). Unique metal cation recognition via crown ether-derivatized oligo(phenyleneethynylene) molecular junction. Journal of Physical Chemistry C, 124(16), 8496-8503. DOI Scopus20 WoS17
2020	Lim, S. Y., Law, C. S., Bertó-Roselló, F., Liu, L., Markovic, M., Ferré-Borrull, J., . . . Santos, A. (2020). Tailor-engineered plasmonic single-lattices: harnessing localized surface plasmon resonances for visible-NIR light-enhanced photocatalysis. Catalysis Science and Technology, 10(10), 3195-3211. DOI Scopus12 WoS9
2020	Wu, X. -H., Chen, F., Yan, F., Pei, L. -Q., Hou, R., Horsley, J. R., . . . Mao, B. -W. (2020). Constructing dual-molecule junctions to probe intermolecular crosstalk. ACS Applied Materials and Interfaces, 12(27), 30584-30590. DOI Scopus6 WoS6
2020	Yeoh, Y. Q., Horsley, J., Yu, J., Polyak, S. W., Jovcevski, B., & Abell, A. D. (2020). Short photoswitchable antibacterial peptides. ChemMedChem, 15(16), 1505-1508. DOI Scopus13 WoS11 Europe PMC3
2020	Pan, X., Zhao, J., Qian, G., Zhang, X., Ruan, Y., Abell, A., & Ebendorff-Heidepriem, H. (2020). Mechanistic insight into the non-hydrolytic sol-gel process of tellurite glass films to attain a high transmission. RSC Advances, 10(4), 2404-2415. DOI Scopus2 WoS2
2020	Law, C. S., Lim, S. Y., Liu, L., Abell, A. D., Marsal, L. F., & Santos, A. (2020). Realization of high-quality optical nanoporous gradient-index filters by optimal combination of anodization conditions. Nanoscale, 12(17), 9404-9415. DOI Scopus21 WoS17 Europe PMC3
2020	Yu, J., Jia, P., Wang, S., Ebendorff-Heidepriem, H., & Abell, A. D. (2020). Electrochemical plasmonic optical fiber probe for real-time insight into coreactant electrochemiluminescence. Sensors and Actuators, B: Chemical, 321, 128469-1-128469-8. DOI Scopus8 WoS7
2020	Horsfall, A. J., Dunning, K. R., Keeling, K. L., Scanlon, D. B., Wegener, K. L., & Abell, A. D. (2020). A bimane‐based peptide staple for combined helical induction and fluorescent imaging. ChemBioChem, 21(23), 1-11. DOI Scopus8 WoS6 Europe PMC3
2020	Chen, X., Yeoh, Y. Q., He, Y., Zhou, C., Horsley, J. R., Abell, A. D., . . . Guo, X. (2020). Unravelling structural dynamics within a photoswitchable single-peptide: a step towards multi-modal bio-inspired nanodevices. Angewandte Chemie International Edition, 59(50), 22554-22562. DOI Scopus17 WoS14 Europe PMC3
2020	Horsfall, A. J., Abell, A. D., & Bruning, J. (2020). Targeting PCNA with peptide mimetics for therapeutic purposes. ChemBioChem, 21(4), 442-450. DOI Scopus22 WoS15 Europe PMC12
2020	McLennan, H. J., Saini, A., Sylvia, G. M., Schartner, E. P., Dunning, K. R., Purdey, M. S., . . . Thompson, J. G. (2020). A biophotonic approach to measure pH in small volumes in vitro: quantifiable differences in metabolic flux around the cumulus-oocyte-complex (COC). Journal of Biophotonics, 13(3), e201960038-1-e201960038-9. DOI Scopus7 WoS7 Europe PMC2
2019	Guo, C., Yu, J., Horsley, J. R., Sheves, M., Cahen, D., & Abell, A. D. (2019). Backbone-constrained peptides: temperature and secondary structure affect solid-state electron transport. Journal of Physical Chemistry B, 123(51), 10951-10958. DOI Scopus5 WoS1
2019	Lim, S. Y., Law, C. S., Liu, L., Markovic, M., Hedrich, C., Blick, R. H., . . . Santos, A. (2019). Electrochemical engineering of nanoporous materials for photocatalysis: fundamentals, advances, and perspectives. Catalysts, 9(12), 988-1-988-34. DOI Scopus18 WoS10
2019	Heng, S., Zhang, X., Pei, J., Adwal, A., Reineck, P., Gibson, B. C., . . . Abell, A. D. (2019). Spiropyran-based nanocarrier: a new Zn²⁺-responsive delivery system with real-time intracellular sensing capabilities. Chemistry - A European Journal, 25(3), 854-862. DOI Scopus15 WoS12 Europe PMC1
2019	Lee, K. J., Tieu, W., Blanco-Rodriguez, B., Paparella, A. S., Yu, J., Hayes, A., . . . Abell, A. D. (2019). Sulfonamide-based inhibitors of biotin protein ligase as new antibiotic leads. ACS Chemical Biology, 14(9), 1990-1997. DOI Scopus5 WoS4 Europe PMC1
2019	Liu, L., Lim, S. Y., Law, C. S., Jin, B., Abell, A. D., Ni, G., & Santos, A. (2019). Light-confining semiconductor nanoporous anodic alumina optical microcavities for photocatalysis. Journal of Materials Chemistry A, 7(39), 22514-22529. DOI Scopus22 WoS22
2019	Eckstein., Law, C. S., Lim, S. Y., Kaur, S., Kumeria, T., Ferré-Borrull, J., . . . Santos, A. (2019). Nanoporous photonic crystals with tailored surface chemistry for ionic copper sensing. Journal of Materials Chemistry C, 7(39), 12278-12289. DOI Scopus14 WoS13
2019	Schumann, N. C., Bruning, J., Marshall, A. C., & Abell, A. D. (2019). The role of N-terminal heterocycles in hydrogen bonding to α-chymotrypsin. Bioorganic and Medicinal Chemistry Letters, 29(3), 396-399. DOI Scopus2 WoS2 Europe PMC1
2019	Pehere, A. D., Nguyen, S., Garlick, S. K., Wilson, D. W., Hudson, I., Sykes, M. J., . . . Abell, A. D. (2019). Tripeptide analogues of MG132 as protease inhibitors. Bioorganic and Medicinal Chemistry, 27(2), 436-441. DOI Scopus6 WoS4 Europe PMC3
2019	Vidanapathirana, A. K., Pullen, B. J., Zhang, R., Duong, M. N., Goyne, J. M., Zhang, X., . . . Psaltis, P. J. (2019). A novel ruthenium-based molecular sensor to detect endothelial nitric oxide. Scientific Reports, 9(1), 1720-1-1720-16. DOI Scopus6 WoS5 Europe PMC4
2019	Pei, J. V., Heng, S., De Ieso, M. L., Sylvia, G., Kourghi, M., Nourmohammadi, S., . . . Yool, A. J. (2019). Development of a photoswitchable lithium-sensitive probe to analyze nonselective cation channel activity in migrating cancer cells. Molecular Pharmacology, 95(5), 573-583. DOI Scopus19 WoS15 Europe PMC8
2019	Bachhuka, A., Heng, S., Vasilev, K., Kostecki, R., Abell, A., & Ebendorff-Heidepriem, H. (2019). Surface functionalization of exposed core glass optical fiber for metal ion sensing. Sensors, 19(8), 1-8. DOI Scopus10 WoS7 Europe PMC3
2019	Lim, S. Y., Law, C. S., Markovic, M., Marsal, L. F., Voelcker, N. H., Abell, A. D., & Santos, A. (2019). Rational management of photons for enhanced photocatalysis in structurally-colored nanoporous anodic alumina photonic crystals. ACS Applied Energy Materials, 2(2), 1169-1184. DOI Scopus24 WoS24
2019	Peddie, V., & Abell, A. D. (2019). Photocontrol of peptide secondary structure through non-azobenzene photoswitches. Journal of Photochemistry and Photobiology C: Photochemistry Reviews, 40, 1-20. DOI Scopus29 WoS25
2019	Lim, S. Y., Law, S., Liu, L., Markovic, M., Abell, A. D., & Santos, A. (2019). Integrating surface plasmon resonance and slow photon effects in nanoporous anodic alumina photonic crystals for photocatalysis. Catalysis Science and Technology, 9(12), 3158-3176. DOI Scopus24 WoS15
2018	Marshall, A., Keiller, B., Pederick, J., Abell, A., & Bruning, J. (2018). Crystal structure of bovine alpha-chymotrypsin in space group P65. Crystals, 8(12), 460. DOI Scopus3 WoS1
2018	Law, S., Lim, S., Macalincag, R., Abell, A. D., & Santos, A. (2018). Light-confining nanoporous anodic alumina microcavities by apodized stepwise pulse anodization. ACS Applied Nano Materials, 1(9), 4418-4434. DOI Scopus20 WoS19
2018	Zhang, X., Heng, S., Pei, J., Morey, J. R., McDevitt, C. A., & Abell, A. D. (2018). A liposomal platform for sensing of extracellular analytes near cells. Biosensors, 8(4), 1-11. DOI Scopus4 WoS4
2018	Paparella, A., Feng, J., Blanco-Rodriguez, B., Feng, Z., Phetsang, W., Blaskovich, M., . . . Abell, A. (2018). A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase. Tetrahedron, 74(12), 1175-1183. DOI Scopus3 WoS3
2018	Paparella, A. S., Lee, K. J., Hayes, A. J., Feng, J., Feng, Z., Cini, D., . . . Abell, A. D. (2018). Halogenation of biotin protein ligase inhibitors improves whole cell activity against Staphylococcus aureus. ACS infectious diseases, 4(2), 175-184. DOI Scopus23 WoS21 Europe PMC5
2018	Sylvia, G., Mak, A., Heng, S., Bachhuka, A., Ebendorff-Heidepriem, H., & Abell, A. (2018). A rationally designed, spiropyran-based chemosensor for magnesium. Chemosensors, 6(2), 1-12. DOI Scopus13 WoS11
2018	Wegener, K. L., McGrath, A. E., Dixon, N. E., Oakley, A. J., Scanlon, D. B., Abell, A. D., & Bruning, J. (2018). Rational design of a 310-helical PIP-box mimetic targeting PCNA - the human sliding clamp. Chemistry - A European Journal, 24(44), 11325-11331. DOI Scopus14 WoS10 Europe PMC7
2018	Lim, S., Law, C., Markovic, M., Kirby, J., Abell, A., & Santos, A. (2018). Engineering the slow photon effect in photoactive nanoporous anodic alumina gradient-index filters for photocatalysis. ACS Applied Materials and Interfaces, 10(28), 24124-24136. DOI Scopus29 WoS29 Europe PMC5
2018	Horsley, J. R., Yu, J., Wegener, K. L., Hoppmann, C., Rück-Braun, K., & Abell, A. D. (2018). Photoswitchable peptide-based ‘on-off’ biosensor for electrochemical detection and control of protein-protein interactions. Biosensors and Bioelectronics, 118, 188-194. DOI Scopus20 WoS16 Europe PMC2
2018	Law, C., Lim, S., Abell, A., Marsal, L., & Santos, A. (2018). Structural tailoring of nanoporous anodic alumina optical microcavities for enhanced resonant recirculation of light. Nanoscale, 10(29), 14139-14152. DOI Scopus30 WoS24 Europe PMC1
2018	Hochscherf, J., Pietsch, M., Tieu, W., Kuan, K., Abell, A., Gütschow, M., & Niefind, K. (2018). Crystal structure of highly glycosylated human leukocyte elastase in complex with an S2′ site binding inhibitor. Acta Crystallographica Section F: Structural Biology Communications, 74(8), 480-489. DOI Scopus6 WoS6 Europe PMC5
2018	Law, C., Lim, S., Abell, A., & Santos, A. (2018). Real-time binding monitoring between human blood proteins and heavy metal ions in nanoporous anodic alumina photonic crystals. Analytical Chemistry, 90(16), 10039-10048. DOI Scopus28 WoS25 Europe PMC5
2018	Yu, J., Horsley, J., & Abell, A. (2018). Peptides as bio-inspired electronic materials: an electrochemical and first-principles perspective. Accounts of Chemical Research, 51(9), 2237-2246. DOI Scopus29 WoS26 Europe PMC6
2018	Law, C., Lim, S., Abell, A., Voelcker, N., & Santos, A. (2018). Nanoporous anodic alumina photonic crystals for optical chemo-and biosensing: fundamentals, advances, and perspectives. Nanomaterials, 8(10), 788-1-788-47. DOI Scopus56 WoS48 Europe PMC11
2018	Purdey, M., McLennan, H., Sutton-McDowall, M., Drumm, D., Zhang, X., Capon, P., . . . Abell, A. (2018). Biological hydrogen peroxide detection with aryl boronate and benzil BODIPY-based fluorescent probes. Sensors and Actuators B: Chemical, 262, 750-757. DOI Scopus35 WoS34
2018	Abell, A. D., Yu, J., Polyak, S., Horsley, J., & Yeoh, Y. Q. (2018). Photopharmacological control of cyclic antimicrobial peptides. ChemBioChem: a European Journal of Chemical Biology, 19(24), 2591-2597. DOI Scopus41 WoS37 Europe PMC15
2018	Thompson, A. P., Salaemae, W., Pederick, J. L., Abell, A. D., Booker, G. W., Bruning, J. B., . . . Polyak, S. W. (2018). Mycobacterium tuberculosis Dethiobiotin Synthetase Facilitates Nucleoside Triphosphate Promiscuity through Alternate Binding Modes. ACS Catalysis, 8(11), 10774-10783. DOI Scopus7 WoS5
2018	Kostecki, R., Heng, S., Mak, A., Ebendorff-Heidepriem, H., Monro, T., & Abell, A. (2018). Control of molecular recognition via modulation of the nanoenvironment. ACS Applied Materials and Interfaces, 10(49), 41866-41870. DOI Scopus4 WoS2
2018	Sylvia, G., Heng, S., Bachhuka, A., Ebendorff-Heidepriem, H., & Abell, A. (2018). A spiropyran with enhanced fluorescence: a bright, photostable and red-emitting calcium sensor. Tetrahedron, 74(12), 1240-1244. DOI Scopus16 WoS15
2018	Wegener, K. L., McGrath, A. E., Dixon, N. E., Oakley, A. J., Scanlon, D. B., Abell, A. D., & Bruning, J. B. (2018). Front Cover: Rational Design of a 3<sub>10</sub>‐Helical PIP‐Box Mimetic Targeting PCNA, the Human Sliding Clamp (Chem. Eur. J. 44/2018). Chemistry – A European Journal, 24(44), 11234. DOI
2017	Heng, S., Mak, A., Kostecki, R., Zhang, X., Pei, J., Stubing, D., . . . Abell, A. (2017). Photoswitchable calcium sensor: ‘On’–‘Off’ sensing in cells or with microstructured optical fibers. Sensors and Actuators, B: Chemical, 252, 965-972. DOI Scopus22 WoS20
2017	Blanco, B., Palasis, K., Adwal, A., Callen, D., & Abell, A. (2017). Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity. Bioorganic and Medicinal Chemistry, 25(19), 5050-5054. DOI Scopus31 WoS27 Europe PMC10
2017	Purdey, M. S., Capon, P. K., Pullen, B. J., Reineck, P., Schwarz, N., Psaltis, P. J., . . . Abell, A. D. (2017). An organic fluorophore-nanodiamond hybrid sensor for photostable imaging and orthogonal, on-demand biosensing. Scientific Reports, 7(1), 15967-1-15967-8. DOI Scopus14 WoS11 Europe PMC2
2017	López-Pérez, B., Pepper, H., Ma, R., Fawcett, B., Pehere, A., Wei, Q., . . . George, J. (2017). Biosynthetically guided structure-activity relationship studies of Merochlorin A, an antibiotic marine natural product. ChemMedChem, 12(23), 1969-1976. DOI Scopus17 WoS15 Europe PMC6
2017	McDowall, M. L., Gosnell, M., Anwer, A., White, M., Purdey, M., Abell, A. D., . . . Thompson, J. G. (2017). Hyperspectral microscopy can detect metabolic heterogeneity within bovine post-compaction embryos incubated under two oxygen concentrations (7% versus 20%). Human Reproduction, 32(10), 2016-2025. DOI Scopus27 WoS22 Europe PMC8
2017	Yu, J.., Horsley, J., & Abell, A. (2017). A controllable mechanistic transition of charge transfer in helical peptides: from hopping to superexchange. RSC Advances, 7(67), 42370-42378. DOI Scopus4 WoS3
2017	Heng, S., Zhang, X., Pei, J., & Abell, A. (2017). A rationally designed reversible 'turn-off' sensor for glutathione. Biosensors, 7(3), 1-13. DOI Scopus12 WoS11 Europe PMC4
2017	Heng, S., Reineck, P., Vidanapathirana, A., Pullen, B., Drumm, D., Ritter, L., . . . Abell, A. (2017). Rationally designed probe for reversible sensing of zinc and application in cells. ACS Omega, 2(9), 6201-6210. DOI Scopus21 WoS17 Europe PMC2
2017	Frkic, R., He, Y., Rodriguez, B., Chang, M., Kuruvilla, D., Ciesla, A., . . . Bruning, J. (2017). Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics. Journal of Medicinal Chemistry, 60(11), 4584-4593. DOI Scopus22 WoS18 Europe PMC8
2017	Pehere, A. D., Zhang, X., & Abell, A. D. (2017). Macrocyclic peptidomimetics prepared by ring-closing metathesis and azide-alkyne cycloaddition. Australian Journal of Chemistry, 70(2), 138-151. DOI Scopus18 WoS18
2017	Law, C., Sylvia, G., Nemati, M., Yu, J., Losic, D., Abell, A., & Santos, A. (2017). Engineering of surface chemistry for enhanced sensitivity in nanoporous interferometric sensing platforms. ACS Applied Materials and Interfaces, 9(10), 8929-8940. DOI Scopus28 WoS26 Europe PMC6
2017	Yu, J., Horsley, J., & Abell, A. (2017). Exploiting the interplay of quantum interference and backbone rigidity on electronic transport in peptides: a step towards bio-inspired quantum interferometers. Molecular Systems Design & Engineering, 2(1), 67-77. DOI Scopus10 WoS9
2017	Stubing, D., Heng, S., Monro, T., & Abell, A. (2017). A comparative study of the fluorescence and photostability of common photoswitches in microstructured optical fibre. Sensors and Actuators B: Chemical, 239, 474-480. DOI Scopus6 WoS6
2016	Zhang, X., Adwal, A., Turner, A., Callen, D., & Abell, A. (2016). New peptidomimetic boronates for selective inhibition of the chymotrypsin-like activity of the 26S proteasome. ACS Medicinal Chemistry Letters, 7(12), 1039-1043. DOI Scopus9 WoS7 Europe PMC4
2016	Feng, J., Paparella, A., Tieu, W., Heim, D., Clark, S., Hayes, A., . . . Abell, A. (2016). New series of BPL inhibitors to probe the ribose-binding pocket of Staphylococcus aureus biotin protein ligase. ACS Medicinal Chemistry Letters, 7(12), 1068-1072. DOI Scopus11 WoS10 Europe PMC4
2016	Carpenter, R., Holman, A., Abell, A., & Grice, K. (2016). Cretaceous fire in Australia: a review with new geochemical evidence, and relevance to the rise of the angiosperms. Australian Journal of Botany, 64(8), 564-578. DOI Scopus14 WoS12
2016	Feng, J., Paparella, A. S., Booker, G. W., Polyak, S. W., & Abell, A. D. (2016). Biotin protein ligase is a target for new antibacterials. Antibiotics, 5(3), 26-1-26-15. DOI Scopus19 WoS18 Europe PMC11
2016	Keeling, K., Cho, O., Scanlon, D., Booker, G., Abell, A., & Wegener, K. (2016). The key position: influence of staple location on constrained peptide conformation and binding. Organic & Biomolecular Chemistry, 14(41), 9731-9735. DOI Scopus6 WoS6 Europe PMC3
2016	Zuber, A., Purdey, M., Schartner, E., Forbes, C., Van Der Hoek, B., Giles, D., . . . Ebendorff-Heidepriem, H. (2016). Detection of gold nanoparticles with different sizes using absorption and fluorescence based method. Sensors and Actuators, B: Chemical, 227, 117-127. DOI Scopus157 WoS125
2016	Cottam Jones, J., Harris, P., Scanlon, D., Forbes, B., Brimble, M., & Abell, A. (2016). Fluorescent IGF-II analogues for FRET-based investigations into the binding of IGF-II to the IGF-1R. Organic and Biomolecular Chemistry, 14(9), 2698-2705. DOI Scopus6 WoS6 Europe PMC1
2016	McDowall, M. L., Wu, L. L., Purdey, M., Abell, A. D., Goldys, E. M., MacMillan, K. L., . . . Robker, R. L. (2016). Non-esterified fatty acid-induced endoplasmic reticulum stress in cattle cumulus oocyte complexes alters cell metabolism and developmental competence. Biology of Reproduction, 94(1), 23 -1-23 -9. DOI Scopus67 WoS63 Europe PMC34
2016	Stubing, D. B., Heng, S., & Abell, A. D. (2016). Crowned spiropyran fluoroionophores with a carboxyl moiety for the selective detection of lithium ions. Organic and Biomolecular Chemistry, 14(15), 3752-3757. DOI Scopus33 WoS27 Europe PMC4
2016	Heng, S., McDevitt, C. A., Kostecki, R., Morey, J. R., Eijkelkamp, B. A., Ebendorff-Heidepriem, H., . . . Abell, A. D. (2016). Microstructured optical fiber-based biosensors: reversible and nanoliter-scale measurement of zinc ions. ACS Applied Materials and Interfaces, 8(20), 12727-12732. DOI Scopus35 WoS31 Europe PMC10
2016	Yu, J., Horsley, J., & Abell, A. (2016). Turning electron transfer 'on-off' in peptides through side-bridge gating. Electrochimica Acta, 209, 65-74. DOI Scopus10 WoS9
2016	Zhang, X., Bruning, J., George, J., & Abell, A. (2016). A mechanistic study on the inhibition of α-chymotrypsin by a macrocyclic peptidomimetic aldehyde. Organic and Biomolecular Chemistry, 14(29), 6970-6978. DOI Scopus11 WoS10
2016	Greenwood, J. E., Tan, J. L., Choong Tzen Ming, J., & Abell, A. D. (2016). Alkalis and skin. Journal of Burn Care and Research, 37(2), 135-141. DOI Scopus13 WoS11 Europe PMC9
2015	Purdey, M., Connaughton, H., Whiting, S., Schartner, E., Monro, T., Thompson, J., . . . Abell, A. (2015). Boronate probes for the detection of hydrogen peroxide release from human spermatozoa. Free Radical Biology & Medicine, 81, 69-76. DOI Scopus37 WoS38 Europe PMC12
2015	Tieu, W., Polyak, S., Paparella, A., Yap, M., Soares Da Costa, T., Ng, B., . . . Abell, A. (2015). Improved synthesis of biotinol-5'-AMP: implications for antibacterial discovery. ACS Medicinal Chemistry Letters, 6(2), 216-220. DOI Scopus18 WoS17 Europe PMC9
2015	Horsley, J., Yu, J., & Abell, A. (2015). The correlation of electrochemical measurements and molecular junction conductance simulations in β-strand peptides. Chemistry, 21(15), 5926-5933. DOI Scopus17 WoS15 Europe PMC2
2015	Sutton-McDowall, M., Purdey, M., Brown, H., Abell, A., Mottershead, D., Cetica, P., . . . Thompson, J. (2015). Redox and anti-oxidant state within cattle oocytes following in vitro maturation with bone morphogenetic protein 15 and follicle stimulating hormone. Molecular Reproduction and Development, 82(4), 281-294. DOI Scopus42 WoS39 Europe PMC16
2015	Kumeria, T., Yu, J., Alsawat, M., Kurkuri, M., Santos, A., Abell, A., & Losic, D. (2015). Photoswitchable membranes based on peptide-modified nanoporous anodic alumina: toward smart membranes for on-demand molecular transport. Advanced Materials, 27(19), 3019-3024. DOI Scopus35 WoS33 Europe PMC8
2015	Kumeria, T., Yu, J., Alsawat, M., Kurkuri, M., Santos, A., Abell, A., & Losic, D. (2015). Membranes: Photoswitchable Membranes Based on Peptide-Modified Nanoporous Anodic Alumina: Toward Smart Membranes for On-Demand Molecular Transport (Adv. Mater. 19/2015). Advanced materials, 27(19), 2950. DOI
2015	Zhang, X., Heng, S., & Abell, A. (2015). Photoregulation of α-chymotrypsin activity by spiropyran-based inhibitors in solution and attached to an optical fiber. Chemistry, 21(30), 10703-10713. DOI Scopus12 WoS9 Europe PMC3
2015	Purdey, M., Thompson, J., Monro, T., Abell, A., & Schartner, E. (2015). A dual sensor for pH and hydrogen peroxide using polymer-coated optical fibre tips. Sensors, 15(12), 31904-31913. DOI Scopus38 WoS35 Europe PMC8
2015	Schartner, E., Tsiminis, G., François, A., Kostecki, R., Warren-Smith, S., Nguyen, L., . . . Monro, T. (2015). Taming the light in microstructured optical fibers for sensing. International Journal of Applied Glass Science, 6(3), 229-239. DOI Scopus39 WoS34
2014	Tieu, W., Jarrad, A. M., Paparella, A. S., Keeling, K. A., Soares da Costa, T. P., Wallace, J. C., . . . Abell, A. D. (2014). Heterocyclic acyl-phosphate bioisostere-based inhibitors of Staphylococcus aureus biotin protein ligase. Bioorganic & Medicinal Chemistry Letters, 24(19), 4689-4693. DOI Scopus19 WoS17 Europe PMC7
2014	Horsley, J., Yu, J., Moore, K., Shapter, J., & Abell, A. (2014). Unraveling the interplay of backbone rigidity and electron rich side-chains on electron transfer in peptides: the realization of tunable molecular wires. Journal of the American Chemical Society, 136(35), 12479-12488. DOI Scopus34 WoS33 Europe PMC12
2014	Pendini, N. R., Yap, M. Y., Polyak, S. W., Cowieson, N. P., Abell, A., Booker, G. W., . . . Wilce, M. C. J. (2014). Erratum: Structural characterisation of Staphylococcus aureus biotin protein ligase and interaction partners: An antibiotic target (Protein Science (2013) 22 (762-773)). Protein Science, 23(1), 121. DOI
2014	Jones, S., Duncan, J., Aitken, S., Coxon, J., & Abell, A. (2014). The preparation of macrocyclic calpain inhibitors by ring closing metathesis and cross metathesis. Australian Journal of Chemistry, 67(9), 1257-1263. DOI Scopus4 WoS4
2014	Chua, K., Pietsch, M., Zhang, X., Hautmann, S., Chan, H., Bruning, J., . . . Abell, A. (2014). Macrocyclic protease inhibitors with reduced peptide character. Angewandte Chemie International Edition, 53(30), 7828-7831. DOI Scopus23 WoS20 Europe PMC8
2014	Paparella, A., Soares Da Costa, T., Yap, M., Tieu, W., Wilce, M., Booker, G., . . . Polyak, S. (2014). Structure guided design of biotin protein ligase inhibitors for antibiotic discovery. Current Topics in Medicinal Chemistry, 14(1), 4-20. DOI Scopus25 WoS25 Europe PMC13
2014	Yu, J., Horsley, J., Moore, K., Shapter, J., & Abell, A. (2014). The effect of a macrocyclic constraint on electron transfer in helical peptides: a step towards tunable molecular wires. Chemical Communications, 50(14), 1652-1654. DOI Scopus16 WoS14 Europe PMC4
2014	Heng, S., Mak, A., Stubing, D., Monro, T., & Abell, A. (2014). Dual sensor for Cd(II) and Ca(II): selective nanoliter-scale sensing of metal ions. Analytical Chemistry, 86(7), 3268-3272. DOI Scopus50 WoS47 Europe PMC10
2014	Soares da Costa, T., Yap, M., Perugini, M., Wallace, J., Abell, A., Wilce, M., . . . Booker, G. (2014). Dual roles of F123 in protein homodimerization and inhibitor binding to biotin protein ligase from Staphylococcus aureus. Molecular Microbiology, 91(1), 110-120. DOI Scopus20 WoS17 Europe PMC12
2013	Heng, S., McDevitt, C., Stubing, D., Whittall, J., Thompson, J., Engler, T., . . . Monro, T. (2013). Microstructured optical fibers and live cells: a water-soluble, photochromic zinc sensor. Biomacromolecules, 14(10), 3376-3379. DOI Scopus29 WoS24 Europe PMC5
2013	Tieu, W., Soares da Costa, T., Yap, M., Keeling, K., Wilce, M., Wallace, J., . . . Abell, A. (2013). Optimising in situ click chemistry: the screening and identification of biotin protein ligase inhibitors. Chemical Science, 4(9), 3533-3537. DOI Scopus36 WoS34
2013	Yu, J., Horsley, J., & Abell, A. (2013). The influence of secondary structure on electron transfer in peptides. Australian Journal of Chemistry, 66(8), 848-851. DOI Scopus15 WoS15
2013	Jones, S., Neilsen, P., Siew, L., Callen, D., Goldfarb, N., Dunn, B., & Abell, A. (2013). A template-based approach to inhibitors of calpain 2, 20S proteasome, and HIV-1 protease. ChemMedChem, 8(12), 1918-1921. DOI Scopus9 WoS8 Europe PMC3
2013	Pendini, N., Yap, M., Polyak, S., Cowieson, N., Abell, A., Booker, G., . . . Wilce, M. (2013). Structural characterization of Staphylococcus aureus biotin protein ligase and interaction partners: An antibiotic target. Protein Science, 22(6), 762-773. DOI Scopus32 WoS28 Europe PMC22
2013	Pehere, A., Pietsch, M., Gutschow, M., Neilsen, P., Pedersen, D., Nguyen, S., . . . Abell, A. (2013). Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors. Chemistry-A European Journal, 19(24), 7975-7981. DOI Scopus26 WoS24 Europe PMC6
2013	Li, Y., Coller, J., Hutchinson, M., Klein, K., Zanger, U., Stanley, N., . . . Somogyi, A. (2013). The CYP2B66 allele significantly alters the N-demethylation of ketamine enantiomers in vitro. Drug Metabolism and Disposition*, 41(6), 1264-1272. DOI Scopus40 WoS34 Europe PMC21
2013	Heng, S., Nguyen, M., Kostecki, R., Monro, T., & Abell, A. (2013). Nanoliter-scale, regenerable ion sensor: sensing with a surface functionalized microstructured optical fibre. RSC Advances, 3(22), 8308-8317. DOI Scopus53 WoS47
2013	Cottam, J., Scanlon, D., Karas, J., Calabrese, A., Pukala, T., Forbes, B., . . . Abell, A. (2013). Chemical synthesis of a fluorescent IGF-II analogue. International Journal of Peptide Research and Therapeutics, 19(1), 61-69. DOI Scopus5 WoS3
2013	Moore, K., Flavel, B., Yu, J., Abell, A., & Shapter, J. (2013). Increased redox-active peptide loading on carbon nanotube electrodes. Electrochimica Acta, 89, 206-211. DOI Scopus17 WoS15
2013	Neilsen, P., Pehere, A., Pishas, K., Callen, D., & Abell, A. (2013). New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity. ACS Chemical Biology, 8(2), 353-359. DOI Scopus19 WoS19 Europe PMC11
2013	Pehere, A., Sumby, C., & Abell, A. (2013). New cylindrical peptide assemblies defined by extended parallel β-sheets. Organic & Biomolecular Chemistry, 11(3), 425-429. DOI Scopus20 WoS19 Europe PMC7
2013	Morton, J., Lee, H., McDermott, J., Robertson, L., Bickerstaffe, R., Jones, M., . . . Abell, A. (2013). A macrocyclic calpain inhibitor slows the development of inherited cortical cataracts in a sheep model. Investigative Ophthalmology and Visual Science, 54(1), 389-395. DOI Scopus22 WoS20 Europe PMC11
2012	Chen, H., Jiao, W., Jones, M., Coxon, J., Morton, J., Bickerstaffe, R., . . . Abell, A. (2012). New tripeptide-based macrocyclic calpain inhibitors formed by n-alkylation of histidine. Chemistry & Biodiversity, 9(11), 2473-2484. DOI Scopus17 WoS14 Europe PMC4
2012	Soares da Costa, T., Tieu, W., Yap, M., Zvarec, O., Bell, J., Turnidge, J., . . . Polyak, S. (2012). Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase. ACS Medicinal Chemistry Letters, 3(6), 509-514. DOI Scopus37 WoS36 Europe PMC18
2012	Soares da Costa, T., Tieu, W., Yap, M., Pendini, N., Polyak, S., Pedersen, D., . . . Abell, A. (2012). Selective inhibition of biotin protein ligase from Staphylococcus aureus. Journal of Biological Chemistry, 287(21), 17823-17832. DOI Scopus54 WoS45 Europe PMC30
2012	Peddie, V., Butcher, R., Robinson, W., Wilce, M., Traore, D., & Abell, A. (2012). Synthesis and conformation of fluorinated β-peptidic compounds. Chemistry-A European Journal, 18(21), 6655-6662. DOI Scopus21 WoS19 Europe PMC6
2012	Zvarec, O., Polyak, S., Tieu, W., Kuan, K., Dai, H., Pedersen, D., . . . Abell, A. (2012). 5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials. Bioorganic & Medicinal Chemistry Letters, 22(8), 2720-2722. DOI Scopus42 WoS34 Europe PMC15
2012	Pehere, A., & Abell, A. (2012). New β-strand templates constrained by Huisgen cycloaddition. Organic Letters, 14(5), 1330-1333. DOI Scopus41 WoS39 Europe PMC18
2012	Polyak, S., Abell, A., Wilce, M., Zhang, L., & Booker, G. (2012). Structure, function and selective inhibition of bacterial acetyl-coa carboxylase. Applied Microbiology and Biotechnology, 93(3), 983-992. DOI Scopus64 WoS61 Europe PMC37
2012	Yu, J., Zvarec, O., Huang, D., Bissett, M., Scanlon, D., Shapter, J., & Abell, A. (2012). Electron transfer through α-peptides attached to vertically aligned carbon nanotube arrays: a mechanistic transition. Chemical Communications, 48(8), 1132-1134. DOI Scopus34 WoS33 Europe PMC11
2012	Peddie, V., & Abell, A. (2012). A study on the diastereoselective synthesis of α-fluorinated β³-amino acids by α-fluorination. Helvetica Chimica Acta, 95(12), 2460-2473. DOI Scopus10 WoS9
2012	Yu, J., Huang, D., Shapter, J., & Abell, A. (2012). Electrochemical and computational studies on intramolecular dissociative electron transfer in β‐peptides. Journal of Physical Chemistry C, 116(50), 26608-26617. DOI Scopus24 WoS24
2011	Stuart, B., Coxon, J., Morton, J., Abell, A., McDonald, D., Aitken, S., . . . Bickerstaffe, R. (2011). Molecular modeling: A search for a calpain inhibitor as a new treatment for cataractogenesis. Journal of Medicinal Chemistry, 54(21), 7503-7522. DOI Scopus19 WoS17 Europe PMC6
2011	Heng, S., Tieu, W., Hautmann, S., Kuan, K., Pedersen, D., Pietsch, M., . . . Abell, A. (2011). New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorganic & Medicinal Chemistry, 19(24), 7453-7463. DOI Scopus44 WoS36 Europe PMC18
2011	Pehere, A., & Abell, A. (2011). Selective N-acylation and N-alkylation of biotin. Journal of Organic Chemistry, 76(22), 9514-9518. DOI Scopus1
2011	Lim, S., Neilsen, P., Sharma, R., Abell, A., & Callen, D. (2011). The application of delivery systems for DNA methyltransferase inhibitors. Biodrugs, 25(4), 227-242. DOI Scopus10 WoS10 Europe PMC7
2011	Wang, T., Tran, T., Scanlon, D., Andreazza, H., Abell, A., & Bowie, J. (2011). Diagnostic di- and triphosphate cyclisation in the negative ion electrospray mass spectra of phosphoSer peptides. Rapid Communications in Mass Spectrometry, 25(18), 2649-2656. DOI Scopus4 WoS4 Europe PMC4
2011	Packwood, D., Brooksby, P., Abell, A., & Downard, A. (2011). pH-dependent wettability of carboxyphenyl films grafted to glassy carbon. Australian Journal of Chemistry, 64(1), 122-126. DOI Scopus7 WoS5
2011	Ellis-Steinborner, S., Scanlon, D., Musgrave, I., Tran, T., Hack, S., Wang, T., . . . Bowie, J. (2011). An unusual kynurenine-containing opioid tetrapeptide from the skin gland secretion of the Australian red tree frog Litoria rubella. Sequence determination by electrospray mass spectrometry. Rapid Communications in Mass Spectrometry, 25(12), 1735-1740. DOI Scopus10 WoS10 Europe PMC6
2011	Zaman, S., Chen, H., & Abell, A. (2011). Studies of a soluble polyethylene glycol immobilized ruthenium catalyst in aqueous media. Tetrahedron Letters, 52(8), 878-880. DOI Scopus7 WoS7
2011	Warren-Smith, S., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2011). Fluorescence-Based Aluminum Ion Sensing using a Surface Functionalized Microstructured Optical Fiber. Langmuir, 27(9), 5680-5685. DOI Scopus71 WoS61 Europe PMC16
2011	Brooksby, P., Anderson, K., Downard, A., & Abell, A. (2011). Voltammetric and electrochemical impedance study of ferrocenyl containing beta-peptide monolayers on gold. The Journal of Physical Chemistry Part C: Nanomaterials and Interfaces, 115(15), 7516-7526. DOI Scopus14 WoS14
2011	Pedersen, D., & Abell, A. (2011). 1,2,3-triazoles in peptidomimetic chemistry. European Journal of Organic Chemistry, 2011(13), 2399-2411. DOI Scopus260 WoS248
2011	Pehere, A., & Abell, A. (2011). An improved large scale procedure for the preparation of N-Cbz amino acids. Tetrahedron Letters, 52(13), 1493-1494. DOI Scopus18 WoS17
2010	Stanley, N., Pedersen, D., Nielsen, B., Kvist, T., Mathiesen, J., Brauner-Osborne, H., . . . Abell, A. (2010). 1,2,3-Triazolyl amino acids as AMPA receptor ligands. Bioorganic & Medicinal Chemistry Letters, 20(24), 7512-7515. DOI Scopus30 WoS30 Europe PMC8
2010	Stanley, N., Hutchinson, M., Kvist, T., Nielsen, B., Mathiesen, J., Brauner-Osborne, H., . . . Taylor, D. (2010). A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity. Bioorganic & Medicinal Chemistry, 18(16), 6089-6098. DOI Scopus5 WoS4
2010	Ballet, S., Marczak, E., Feytens, D., Salvadori, S., Sasaki, Y., Abell, A., . . . Tourwe, D. (2010). Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds. Bioorganic & Medicinal Chemistry Letters, 20(5), 1610-1613. DOI Scopus6 WoS6 Europe PMC3
2010	Brooksby, P., Anderson, K., Downard, A., & Abell, A. (2010). Electrochemistry of ferrocenoyl β-peptide monolayers on gold. Langmuir, 26(2), 1334-1339. DOI Scopus21 WoS19 Europe PMC7
2010	Pearson, D., & Abell, A. (2010). Structural optimization of photoswitch ligands for surface attachment of α-chymotrypsin and regulation of its surface binding. Chemistry-A European Journal, 16(23), 6983-6992. DOI Scopus17 WoS16 Europe PMC4
2010	Peddie, V., Pietsch, M., Bromfield, K., Pike, R., Duggan, P., & Abell, A. (2010). Fluorinated β²- and β³-amino acids: synthesis and inhibition of α-chymotrypsin. Synthesis-Stuttgart, 2010(11), 1845-1859. DOI Scopus39 WoS33
2010	Pietsch, M., Chua, K., & Abell, A. (2010). Calpains: Attractive targets for the development of synthetic inhibitors. Current Topics in Medicinal Chemistry, 10(3), 270-293. DOI Scopus61 WoS57 Europe PMC36
2009	Ebert, M., Gardiner, J., Ballet, S., Abell, A., & Seebach, D. (2009). Synthesis and high-resolution NMR structure of a β³-octapeptide with and without a tether introduced by olefin metathesis. Helvetica Chimica Acta, 92(12), 2643-2658. DOI Scopus17 WoS13
2009	Jones, S., Jones, M., McNabb, S., Aitken, S., Coxon, J., & Abell, A. (2009). N-heterocyclic dipeptide aldehyde calpain inhibitors. Protein and Peptide Letters, 16(12), 1466-1472. DOI Scopus3 WoS3 Europe PMC1
2009	Zaman, S., & Abell, A. (2009). A robust and recyclable ruthenium catalyst immobilised on polyethylene glycol. Tetrahedron Letters, 50(38), 5340-5343. DOI Scopus17 WoS14
2009	Abell, A., Alexander, N., Aitken, S., Chen, H., Coxon, J., Jones, M., . . . Muscroft-Taylor, A. (2009). Synthesis of macrocyclic β-Strand memplates by ring closing metathesis. Journal of Organic Chemistry, 74(11), 4354-4356. DOI Scopus43 WoS39 Europe PMC12
2009	Abell, A., Jones, M., Coxon, J., Morton, J., Aitken, S., McNabb, S., . . . Bickerstaffe, R. (2009). Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors. Angewandte Chemie-International Edition, 48(8), 1455-1458. DOI Scopus61 WoS56 Europe PMC20
2009	Jones, M., Coxon, J., McNabb, S., Mehrtens, J., Alexander, N., Jones, S., . . . Abell, A. (2009). Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts. Australian Journal of Chemistry, 62(7), 671-675. DOI Scopus3 WoS6
2009	Zaman, S., Curnow, O., & Abell, A. (2009). Development of Aqueous Metathesis Catalysts. Australian Journal of Chemistry, 62(2), 91-100. DOI Scopus30 WoS23
2008	Jones, M., Morton, J., Coxon, J., McNabb, S., Lee, H., Aitken, S., . . . Abell, A. (2008). Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors. Bioorganic & Medicinal Chemistry, 16(14), 6911-6923. DOI Scopus21 WoS20 Europe PMC5
2008	Pearson, D., & Abell, A. (2008). D-Leu-L-Phe-containing dipeptide inhibitors of -chymosrypsin- the role of the N- and C-termini in enzyme affinity. ARKIVOC, 2008(12), 85-93. DOI WoS1
2008	Lee, H., Morton, J., Robertson, L., McDermott, J., Bickerstaffe, R., Abell, A., . . . Coxon, J. (2008). Evaluation of a novel calpain inhibitor as a treatment for cataract. Clinical and Experimental Ophthalmology, 36(9), 852-860. DOI Scopus15 WoS14 Europe PMC6
2008	Ballet, S., Pietsch, M., & Abell, A. (2008). Multiple ligands in opioid research. Protein and Peptide Letters, 15(7), 668-682. DOI Scopus44 WoS40 Europe PMC22
2008	Pearson, D., Alexander, N., & Abell, A. (2008). Improved photocontrol of alpha-chymotrypsin activity: Peptidomimetic trifluoromethylketone photoswitch enzyme inhibitors. Chemistry-A European Journal, 14(24), 7358-7365. DOI Scopus26 WoS22 Europe PMC10
2008	Brooksby, P., Schiel, D., & Abell, A. (2008). Electrochemistry of catechol terminated monolayers with Cu(II), Ni(II) and, Fe(III) cations: A model for the marine adhesive interface. Langmuir, 24(16), 9074-9081. DOI Scopus26 WoS26 Europe PMC7
2008	Vernall, A., Ballet, S., & Abell, A. (2008). Cross-metathesis and ring-closing metathesis reactions of amino acid-based substrates. Tetrahedron, 64(18), 3980-3997. DOI Scopus11 WoS11
2008	Edmonds, M., Graichen, F., Gardiner, J., & Abell, A. (2008). Enantioselective synthesis of α-fluorinated β²-amino acids. Organic Letters, 10(5), 885-887. DOI Scopus36 WoS36 Europe PMC7
2007	Paulik, M., Brooksby, P., Abell, A., & Downard, A. (2007). Grafting aryl diazonium cations to polycrystalline gold: Insights into film structure using gold oxide reduction redox probe electrochemistry and contact angle behavior. The Journal of Physical Chemistry Part C: Nanomaterials and Interfaces, 111(21), 7808-7815. DOI Scopus85 WoS79
2007	Abell, A., Jones, M., Neffe, A., Aitken, S., Cain, T., Payne, R., . . . Morton, J. (2007). Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: New anticataract agents. Journal of Medicinal Chemistry, 50(12), 2916-2920. DOI Scopus42 WoS37 Europe PMC16
2007	McCarthy, A., Hartmann, R., & Abell, A. (2007). Evaluation of 4'-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5a-reductase. Bioorganic & Medicinal Chemistry Letters, 17(13), 3603-3607. DOI Scopus14 WoS14 Europe PMC1
2007	Zaman, S., Kitamura, M., & Abell, A. (2007). Synthesis of 5-phenyl 2-functionalized pyrroles by amino Heck and Tandem amino Heck carbonylation reactions. Australian Journal of Chemistry, 60(8), 624-626. DOI Scopus15 WoS15
2007	Mathad, R., Jaun, B., Flogel, O., Gardiner, J., Loweneck, M., Codee, J., . . . Abell, A. (2007). NMR-solution structures of fluoro-substituted β-peptides: A 3 14-helix and a hairpin turn. The first case of a 90° O=C-C-F dihedral angle in an a-fluoro-amide group. Helvetica Chimica Acta, 90(12), 2251-2273. DOI Scopus56 WoS56
2007	Pearson, D., Downard, A., Muscroft-Taylor, A., & Abell, A. (2007). Reversible photoregulation of binding of α-chymotrypsin to a gold surface. Journal of the American Chemical Society, 129(48), 14862-14863. DOI Scopus58 WoS55 Europe PMC21
2007	Payne, R., Peyrot, F., Kerbarh, O., Abell, A., & Abell, C. (2007). Rational Design, Synthesis, and Evaluation of Nanomolar Type II Dehydroquinase Inhibitors. ChemMedChem, 2(7), 1015-1029. DOI Scopus30 WoS30 Europe PMC16
2007	Payne, R., Riboldi-Tunnicliffe, A., Kerbarh, O., Abell, A., Lapthorn, A., & Abell, C. (2007). Design, Synthesis, and Structural Studies on Potent Biaryl Inhibitors of Type II Dehydroquinases. ChemMedChem, 2(7), 1010-1013. DOI Scopus22 WoS22 Europe PMC14
2006	Brooksby, P., Anderson, K., Downard, A., & Abell, A. (2006). Olefin Cross-Metathesis of Vinyl-Terminated Self-Assembled Monolayer (SAM) on Au(111): Electrochemical Study Using a Ferrocenyl Redox Center. Langmuir, 22(22), 9304-9312. DOI Scopus7 WoS8 Europe PMC3
2006	Gardiner, J., Aitken, S., McNabb, S., Zaman, S., & Abell, A. (2006). Ring closing metathesis of α- and β- amino acid derived dienes. Journal of Organometallic Chemistry, 691(24-25), 5487-5496. DOI Scopus13 WoS12
2006	McCarthy, A., Thomson, B., Shaw, I., & Abell, A. (2006). Estrogenicity of pyrethroid insecticide metabolites. Journal of Environmental Monitoring, 8(1), 197-202. DOI Scopus99 WoS92 Europe PMC43
2006	Zaman, S., Campaner, P., & Abell, A. (2006). Synthesis of amino acid derived seven-membered lactams by RCM and their evaluation against HIV protease. Bioorganic & Medicinal Chemistry, 14(24), 8323-8331. DOI Scopus14 WoS14 Europe PMC3
2006	Pearson, D., & Abell, A. (2006). Photoswitch inhibitors of α-chymotrypsin-increased substitution and peptidic character in peptidomimetic boronate esters. Organic & Biomolecular Chemistry, 4(19), 3618-3625. DOI Scopus29 WoS28 Europe PMC12
2006	Abell, A., & Harvey, A. (2006). Synthesis of a [1,4]dioxane-2,5-dione based-peptidomimetic scaffold. ARKIVOC, 2006(3), 72-76. Scopus1 WoS1
2006	Pearson, D. S., Alexander, N. A., & Abell, A. D. (2006). Light controlled switching of protease inhibition by peptidomimetics. JOURNAL OF PEPTIDE SCIENCE, 12, 167. WoS1
2005	Payne, R. J., Toscano, M. D., Bulloch, E. M. M., Aoell, A. D., & Abell, C. (2005). Design and synthesis of aromatic inhibitors of anthranilate synthase. Organic and Biomolecular Chemistry, 3(12), 2271-2281. DOI Scopus18 WoS19 Europe PMC13
2005	Payne, R., Bulloch, E., Abell, A., & Abell, C. (2005). Design and synthesis of aromatic inhibitors of anthranilate synthase. Organic & Biomolecular Chemistry, 3(20), 3629-3635. DOI Scopus15 WoS14 Europe PMC9
2005	Zaman, S., Mitsuru, K., & Abell, A. (2005). Synthesis of Trisubstituted Imidazoles by Palladium-Catalyzed Cyclization of O-Pentafluorobenzoylamidoximes: Application to Amino Acid Mimetics with a C-Terminal Imidazole. Organic Letters, 7(4), 609-611. DOI Scopus125 WoS118 Europe PMC30
2005	Abell, A., Brown, K., Coxon, J., Jones, M., Miyamoto, S., Neffe, A., . . . Stuart, B. (2005). Synthesis and evaluation of eight-membered cyclic pseudo-dipeptides. Peptides, 26(2), 251-258. DOI Scopus9 WoS9 Europe PMC1
2005	Graichen, F., Giles, K., Abell, A., & Garrill, A. (2005). Removal of the nitro and phenyl groups from NPPB decreases its inhibitory effect on cytoplasmic streaming in the alga Nitella hookeri. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire, 83(2), 133-139. DOI Scopus1 WoS1 Europe PMC1
2005	Aitken, S., & Abell, A. (2005). Olefin metathesis: Catalyst development, microwave catalysis, and domino applications. Australian Journal of Chemistry, 58(1), 3-13. DOI Scopus32 WoS27
2005	Payne, R., Kerbarh, O., Miguel, R., Abell, A., & Abell, C. (2005). Inhibition studies on salicylate synthase. Organic & Biomolecular Chemistry, 3(10), 1825-1827. DOI Scopus31 WoS27 Europe PMC17
2005	Neffe, A., & Abell, A. (2005). Developments in the design and synthesis of calpain inhibitors. Current Opinion in Drug Discovery & Development, 8(6), 684-700. Scopus34 WoS31 Europe PMC12
2005	ABELL, A. (2005). Design, Synthesis and Evaluation of Peptidomimetic Inhibitors of Proteases. Peptide science : proceedings of the ... Japanese Peptide Symposium, 2004, 63-66.
2004	Anderson, K. H., Gardiner, J., & Abell, A. D. (2004). FUNCTIONALISED β-AMINO ACIDS. JOURNAL OF PEPTIDE SCIENCE, 10, 160.
2004	Abell, A. D. (2004). Chemistry at the interface. AUSTRALIAN JOURNAL OF CHEMISTRY, 57(9), 819. DOI
2004	Abell, A. D., & Vernall, A. J. (2004). CROSS-METATHESIS REACTIONS OF AMINO ACID-DERIVED COMPOUNDS. JOURNAL OF PEPTIDE SCIENCE, 10, 137.
2004	Martyn, D., & Abell, A. (2004). The Synthesis and Testing of α-(Hydroxymethyl) pyrroles as DNA Binding Agents. Australian Journal of Chemistry, 57(11), 1073-1077. DOI Scopus4 WoS4
2004	Gardiner, J., & Abell, A. (2004). Synthesis and solid state conformation of phenylalanine mimetics constrained in a proline-like conformation. Organic & Biomolecular Chemistry, 2(16), 2365-2370. DOI Scopus12 WoS9 Europe PMC3
2004	Gardiner, J., Anderson, K., Downard, A., & Abell, A. (2004). The synthesis of cyclic β-amino acid esters from Methionone, Allylglycine, and Serine. Journal of Organic Chemistry, 69(10), 3375-3382. DOI Scopus42 WoS40 Europe PMC9
2004	Le Sann, C., & Abell, A. (2004). Synthesis and Properties of a Mesylated ArgoGel Resin. Australian Journal of Chemistry, 57(4), 355-358. DOI Scopus3 WoS3
2004	Gardiner, J., & Abell, A. (2004). Synthesis and X-ray structure of functionalised proline mimics. Arkivoc (Online Ed), 2004(10), 46-52. DOI
2004	Daines, A., & Abell, A. (2004). The preparation of side chain functionalized analogues of coenzyme Q for protein conjugation studies. Organic & Biomolecular Chemistry, 2(16), 2371-2375. DOI Scopus4 WoS4 Europe PMC2
2004	Payne, R., Brown, K., Coxon, J., Morton, J., Lee, H., & Abell, A. (2004). Peptidic aldehydes based on α- and β-amino acids: synthesis, inhibition of m-calpain, and anti-cataract properties. Australian Journal of Chemistry, 57(9), 877-884. DOI Scopus11 WoS12
2004	Payne, R., Daines, A., Clark, B., & Abell, A. (2004). Synthesis and protein conjugation studies of vitamin K analogues. Bioorganic & Medicinal Chemistry, 12(22), 5785-5791. DOI Scopus9 WoS9 Europe PMC2
2004	Le Sann, C., Gower, M., & Abell, A. (2004). Inhibitors of types I and II dehydroquinase. Mini - Reviews in Medicinal Chemistry, 4(7), 747-756. Scopus7 WoS7 Europe PMC2
2004	Vernall, A., & Abell, A. (2004). Cross-metathesis coupling of sugars and fatty acids to lysine and cysteine. Organic & Biomolecular Chemistry, 2(18), 2555-2557. DOI Scopus18 WoS16 Europe PMC3
2003	Giles, K., Humphries, M., Abell, A., & Garrill, A. (2003). The synthesis of NPPB and NPBB by reductive amination and the effects of these compounds on K⁺ channels of the alga Nitella hookeri. Bioorganic & Medicinal Chemistry Letters, 13(2), 293-295. DOI Scopus3 WoS3 Europe PMC2
2003	Humphries, M., Murphy, J., Phillips, A., & Abell, A. (2003). Synthesis of functionalized piperidinones. Journal of Organic Chemistry, 68(6), 2432-2436. DOI Scopus23 WoS20 Europe PMC3
2003	Le Sann, C., Abell, C., & Abell, A. (2003). A Convenient Method for the Synthesis of Dehydroquinic Acid. Synthetic Communications, 33(4), 527-533. DOI Scopus8 WoS8
2003	Gardiner, J., & Abell, A. (2003). A diastereoselective synthesis of the tetrahydropyridazinone core of 2-oxo-1,6-diazobicyclo[4.3.0]nonane-9-carboxylate-based peptidomimetics starting from (S)-phenylalanine. Tetrahedron Letters, 44(22), 4227-4230. DOI Scopus20 WoS19
2003	Martyn, D., Vernall, A., Clark, B., & Abell, A. (2003). Ring-deactivated hydroxyalkylpyrrole-based inhibitors of alpha-chymotrypsin: synthesis and mechanism of action. Organic & Biomolecular Chemistry, 1(12), 2103-2110. DOI Scopus21 WoS20 Europe PMC5
2003	Daines, A., Payne, R., Humphries, M., & Abell, A. (2003). The synthesis of naturally occurring vitamin K and vitamin K analogues. Current Organic Chemistry, 7(16), 1625-1634. DOI Scopus69 WoS63
2003	Vernall, A., & Abell, A. (2003). Cross metathesis of nitrogen-containing systems. Aldrichimica Acta, 36(3), 93-105. DOI Scopus92 WoS89
2003	Martyn, D. C., & Abell, A. D. (2003). N-[5-(3-phenylpropionyl)-1H-pyrrole-2-carbonyl]-l-proline methyl ester. MolBank, 2003(3), M338. DOI
2003	Martyn, D. C., & Abell, A. D. (2003). (R,s)-benzyl 5-(1-hydroxyethyl)-1h-pyrrole-2-carboxylate. MolBank, 2003(3), M337. DOI
2002	Abell, A., & Gardiner, J. (2002). Synthesis of substituted cyclohexenyl-based beta-amino acids by ring-closing metathesis. Organic Letters, 4(21), 3663-3666. DOI Scopus33 WoS31 Europe PMC5
2002	Abell, A., Martyn, D., May, B., & Nabbs, B. (2002). An amino acid N-derivatising group that can be coloured on demand. Tetrahedron Letters, 43(20), 3673-3675. DOI Scopus6 WoS4
2002	Payne, R., & Abell, A. (2002). Protein binding studies of vitamin K analogues for use in an immunological assay. Chemistry in New Zealand, 66(1), 16-20.
2002	May, B., & Abell, A. (2002). α-Methylene tetrazole-based peptidomimetics: synthesis and inhibition of HIV protease. Journal of the Chemical Society. Perkin Transactions 1, 2(2), 172-178. DOI Scopus92 WoS78
2002	Le Sann, C., Abell, C., & Abell, A. (2002). A simple method for the preparation of 3-hydroxyiminodehydroquinate, a potent inhibitor of type II dehydroquinase. Journal of the Chemical Society. Perkin Transactions 1, 18(18), 2065-2068. DOI Scopus8 WoS9
2001	Abell, A., & Gower, M. (2001). New Herbicidal and Antimicrobial Agents that Inhibit the Shikimate Pathway. New Zealand Science Review, 58(3), 87-90.
2001	Zubarev, V., Trifonov, R., Filichev, V., Ostrovskii, V., Abell, A., & Edmonds, M. (2001). Synthesis, X-ray and conformational studies of novel tetrazole-containing macrocyles: 4,13-dioxa-1,7,8,9,17,18,19,20-octaazatricyclo[14.2.1⁷, ¹⁰]icosa-8,10(20),16(19),17-tetraene and 4,14-dioxa-1,7,8,9,10,18,19,20-octaazatricyclo[15.2.1.0⁷, ¹⁰]icosa-8. Journal of the Chemical Society. Perkin Transactions 2, 3(3), 417-421. DOI WoS10
2001	Abell, A., & Nabbs, B. (2001). Ring-deactivated hydroxymethylpyrroles as inhibitors of α-chymotrypsin. Bioorganic & Medicinal Chemistry, 9(3), 621-628. DOI Scopus16 WoS15 Europe PMC6
2001	Edmonds, M., & Abell, A. (2001). Design and synthesis of a conformationally restricted trans peptide isostere based on the bioactive conformations of saquinavir and nelfinavir. Journal of Organic Chemistry, 66(11), 3747-3752. DOI Scopus34 WoS31 Europe PMC7
2001	May, B., & Abell, A. (2001). The synthesis and crystal structure of alpha-keto tetrazole-based dipeptide mimics. Tetrahedron Letters, 42(33), 5641-5644. DOI Scopus61 WoS56
2001	Harvey, A., & Abell, A. (2001). α-Ketoester-based photobiological switches: synthesis, peptide chain extension and assay against α-chymotrypsin. Bioorganic & Medicinal Chemistry Letters, 11(18), 2441-2444. DOI Scopus29 WoS23
2001	Martyn, D., Hoult, D., & Abell, A. (2001). Stereocontrol of the Horner-Wadsworth-Emmons Reaction: Application to the Synthesis of HIV-1 Protease Inhibitors. Australian Journal of Chemistry, 54(6), 391-396. DOI Scopus10 WoS10
2001	Abell, A. (2001). Heterocyclic-based peptidomimetics. Letters in Peptide Science, 8(3-5), 267-272. DOI Scopus36 WoS30
2001	May, B., & Abell, A. (2001). The synthesis and solid state structure of (8S)-8-benzyl-8,9-dihydro-7H-tetrazolo[1,5-d][1,4]diazepin-6-one. Chemical Communications, 20(20), 2080-2081. DOI Scopus8 WoS6 Europe PMC1
2001	Harvey, A., & Abell, A. (2001). Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin.. Bioorganic & medicinal chemistry letters, 11(18), 2441-2444. DOI Europe PMC14
2000	Abell, A. D., Prince, M. J., McNulty, A. M., & Neubauer, B. L. (2000). Simple Bi- and tricyclic inhibitors of human steroid 5α-Reductase. Bioorganic and Medicinal Chemistry Letters, 10(17), 1909-1911. DOI Scopus12 WoS11 Europe PMC2
2000	Gerrard, J. A., Prince, M. J., & Abell, A. D. (2000). Kinetic characterisation of ene-diol-based inhibitors of α-amylase. Bioorganic and Medicinal Chemistry Letters, 10(14), 1575-1576. DOI Scopus4 WoS2 Europe PMC1
2000	Phillips, A. J., Morris, J. C., & Abell, A. D. (2000). Progress towards an intramolecular Diels-Alder ring-expansion approach to taxinine: The interplay of Lewis acids and high pressure. Tetrahedron Letters, 41(15), 2723-2727. DOI Scopus19 WoS17
1999	Abell, A. D., Oldham, M. D., Moore, M. M., & Robinson, W. T. (1999). The synthesis and X-ray crystal structure of phenylalanine-based N-benzyloxysuccinimides. Australian Journal of Chemistry, 52(10), 977-981. DOI
1999	Phillips, A. J., & Abell, A. D. (1999). Ring-closing metathesis of nitrogen-containing compounds: Applications to heterocycles, alkaloids, and peptidomimetics. Aldrichimica Acta, 32(3), 75-88. Scopus354 WoS348
1999	Abell, A. D., Nabbs, B. K., Battersby, A. R., Thompson, A., & Dolphin, D. (1999). Synthesis and properties of ring-deactivated Deuterated (hydroxymethyl)pyrroles. Chemtracts, 12(7), 534-538.
1999	Martyn, D. C., Moore, M. J. B., & Abell, A. D. (1999). Succinimide and saccharin-based enzyme-activated inhibitors of serine proteases. Current Pharmaceutical Design, 5(6), 405-415. Scopus31 WoS33 Europe PMC9
1999	Nabbs, B. K., & Abell, A. D. (1999). The synthesis and P388 cytotoxicity of mycalazol 11 and related 5-acyl- 2-hydroxymethylpyrroles. Bioorganic and Medicinal Chemistry Letters, 9(3), 505-508. DOI Scopus9 WoS6
1999	Abell, A. D., & Oldham, M. D. (1999). Leucine-phenylalanine dipeptide-based N-mesyloxysuccinimides: Synthesis of all four stereoisomers and their assay against serine proteases. Bioorganic and Medicinal Chemistry Letters, 9(3), 497-500. DOI Scopus20 WoS20 Europe PMC4
1999	Abell, A. D., & Gardiner, J. (1999). Synthesis of lactam-based peptidomimetics from β-keto esters and β- keto amides. Journal of Organic Chemistry, 64(26), 9668-9672. DOI Scopus17 WoS18
1999	Abell, A. D., & Nabbs, B. K. (1999). Properties and reactions of ring-deactivated deuterated hydroxymethylpyrroles. Organic Letters, 1(9), 1403-1405. DOI Scopus4 WoS6
1999	May, B. C. H., & Abell, A. D. (1999). A convenient preparation of (2SR,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid; an important peptide bond isostere. Synthetic Communications, 29(14), 2515-2525. DOI Scopus7 WoS7
1998	Abell, A. D., Nabbs, B. K., & Battersby, A. R. (1998). Synthesis and properties of ring-deactivated deuterated (hydroxymethyl)pyrroles. Journal of the American Chemical Society, 120(8), 1741-1746. DOI Scopus36 WoS35
1998	Abell, A. D., Nabbs, B. K., & Battersby, A. R. (1998). The reaction of N-magnesium derivatives of pyrroles with N- mesylchloromethylpyrroles: A synthesis of dipyrrylmethanes. Journal of Organic Chemistry, 63(23), 8163-8169. DOI Scopus26 WoS25
1998	Abell, A. D., Gardiner, J., Phillips, A. J., & Robinson, W. T. (1998). Synthesis and X-ray structure of a 1,2,3,6-tetrahydropyridine-based phenylalanine mimetic. Tetrahedron Letters, 39(51), 9563-9566. DOI Scopus21 WoS18
1998	Abell, A. D., Litten, J. C., & Nabbs, B. K. (1998). <SUP>1</SUP>H NMR study of the hydrolysis of <i>N</i>-acylhydroxy[<SUP>2</SUP>H]methylpyrroles. CHEMICAL COMMUNICATIONS, (8), 919-920. DOI WoS10
1998	Abell, A. D., Litten, J. C., & Nabbs, B. K. (1998). <sup>1</sup>H NMR study of the hydrolysis of N-acylhydroxy[<sup>2</sup>H]methylpyrroles. Chemical Communications, (8), 919-920. DOI Scopus10
1998	Abell, A. D., Ratcliffe, M. J., & Gerrard, J. (1998). Ascorbic acid-based inhibitors of α-amylases. Bioorganic and Medicinal Chemistry Letters, 8(13), 1703-1706. DOI Scopus21 WoS22 Europe PMC7
1998	Abell, A. D., Phillips, A. J., Budhia, S., McNulty, A. M., & Neubauer, B. L. (1998). The preparation and biological activity of lactam-based, non-steroidal, inhibitors of human type-1 steroid 5α-reductase. Australian Journal of Chemistry, 51(5), 389-396. DOI Scopus5 WoS4
1997	Abell, A. D., Brandt, M., Levy, M. A., & Holt, D. A. (1997). Preparation and biological activity of tricyclic non-steroidal inhibitors of human steroid 5α-reductase. Journal of the Chemical Society - Perkin Transactions 1, (11), 1663-1667. DOI Scopus9 WoS8
1997	Abell, A. D., Hoult, D. A., Bergman, D. A., & Fairlie, D. P. (1997). Simple cis-epoxide-based inhibitors of HIV-1 protease. Bioorganic and Medicinal Chemistry Letters, 7(22), 2853-2856. DOI Scopus12 WoS12
1997	Carr, A. C., Winterbourn, C. C., Blunt, J. W., Phillips, A. J., & Abell, A. D. (1997). Nuclear magnetic resonance characterization of 6α-chloro-5β- cholestane-3β,5-diol formed from the reaction of hypochlorous acid with cholesterol. Lipids, 32(4), 363-367. DOI Scopus21 WoS21 Europe PMC5
1997	Abell, A. D., Blunt, J. W., Foulds, G. J., & Munro, M. H. G. (1997). Chemistry of the mycalamides: Antiviral and antitumour compounds from a New Zealand marine sponge. Part 6. The synthesis and testing of analogues of the C(7)-C(10) fragment. Journal of the Chemical Society - Perkin Transactions 1, (11), 1647-1654. DOI Scopus24 WoS17
1997	Abell, A. D., & Foulds, G. J. (1997). Synthesis of a cis-conformationally restricted peptide bond isostere and its application to the inhibition of the HIV-1 protease. Journal of the Chemical Society - Perkin Transactions 1, (17), 2475-2482. DOI Scopus78 WoS58
1997	Abell, A. D., Edwards, R. A., & Oldham, M. D. (1997). Chemistry and X-ray crystallographic structure of N-protected (5-oxo-1,3-oxazolidin-4-yl)acetic acids: Versatile intermediates in the synthesis of peptidomimetics. Journal of the Chemical Society - Perkin Transactions 1, (11), 1655-1662. DOI Scopus8 WoS7
1997	Abell, A. D., & Oldham, M. D. (1997). Synthesis and X-ray crystallographic structure of leucine-phenylalanyl succinimide-based pseudopeptides. Journal of Organic Chemistry, 62(5), 1509-1513. DOI Scopus38 WoS41
1996	Abell, A. D., Brandt, M., Levy, M. A., & Holt, D. A. (1996). A comparison of steroidal and non-steroidal inhibitors of human steroid 5α-reductase: New tricyclic aryl acid inhibitors of the type-1 isozyme. Bioorganic and Medicinal Chemistry Letters, 6(4), 481-484. DOI Scopus18 WoS15
1996	Abell, A. D., Taylor, J. M., & Oldham, M. D. (1996). Self-addition products from the alkylation of amino acid-derived oxazolidinones: X-ray molecular structures of (2R,4S,1′S)-3-benzoyl-4-[benzoylamino(phenyl)methyl]-4-benzyl-2-phenyl-1, 3-oxazolidin-5-one, (2R,4S,1′S)- and (2R,4S,1′R)-3-benzoyl-4-[benzoylamino(phenyl)methyl]-4-isopropyl-2-phenyl- 1,3-oxazolidin-5-one. Journal of the Chemical Society - Perkin Transactions 1, (11), 1299-1304. DOI Scopus8 WoS6
1996	Abell, A. D., Brandt, M., Levy, M. A., & Holt, D. A. (1996). The preparation and evaluation of (+/-)-trans-1-diazo-8-methoxy-4a-methyl-1,2,3,4,4a,9,10,10a-octahydro- phenanthren-2-one as an inhibitor of human type-1 steroid 5α-reductase. Bioorganic and Medicinal Chemistry Letters, 6(7), 883-884. DOI Scopus3 WoS4
1995	Holt, D. A., Yamashita, D. S., Konialian-Beck, A. L., Luengo, J. I., Abell, A. D., Bergsma, D. J., . . . Levy, M. A. (1995). Benzophenone- and Indolecarboxylic Acids: Potent Type-2 Specific Inhibitors of Human Steroid 5α-Reductase. Journal of Medicinal Chemistry, 38(1), 13-15. DOI Scopus50 WoS52 Europe PMC18
1995	Abell, A. D., Oldham, M. D., & Taylor, J. M. (1995). Synthesis of Cyclic Acylated Enamino Esters from Enol Lactones, 4-Keto Amides, and 5-Hydroxy Lactams. Journal of Organic Chemistry, 60(5), 1214-1220. DOI Scopus22 WoS22
1995	Abell, A. D., & Henderson, B. R. (1995). Steroidal and non-steroidal inhibitors of steroid 5α-reductase. Current Medicinal Chemistry, 2(1), 583-597. Scopus38 WoS42
1995	Abell, A. D., Oldham, M. D., & Taylor, J. M. (1995). Synthesis of phenylalanine-based cyclic acylated enamino ester dipeptide analogues: Inhibitors of α-chymotrypsin. X-ray molecular structure of (2′S,4′R)-4′-benzyl-3′-benzyloxycarbonyl-5′-oxo- 2′-phenyloxazolidin-4′-ylacetic acid. Journal of the Chemical Society, Perkin Transactions 1, (7), 953-961. DOI Scopus14 WoS12
1994	Abell, A. D., Hoult, D. A., Morris, K. B., Taylor, J. M., & Trent, J. O. (1994). Additions and Corrections: Halogenation of Keto Acid Phosphoranes:Synthesis of Halo Enol Lactones and Haloallenes (J. Org. Chem. (1993) 58(6) (1531–1537)(10.1021/jo00058a039)). Journal of Organic Chemistry, 59(5), 1230. DOI
1994	Abell, A. D., Hoult, D. A., Morris, K. B., Taylor, J. M., & Trent, J. O. (1994). Erratum: Halogenation of keto acid phosphoranes: Synthesis of halo enol lactones and haloallenes (Journal of Organic Chemistry (1993) 58, (1531)). Journal of Organic Chemistry, 59(5), 1230.
1994	Abell, A. D., Erhard, K. F., Yen, H. K., Yamashita, D. S., Brandt, M., Mohammed, H., . . . Holt, D. A. (1994). Preparative chiral HPLC separation of all possible stereoisomers of LY191704 and LY266111 and their in vitro inhibition of human types 1 and 2 steroid 5α-reductases. Bioorganic and Medicinal Chemistry Letters, 4(11), 1365-1368. DOI Scopus25 WoS22
1994	Abell, A. D., Brandt, M., Levy, M. A., & Holt, D. A. (1994). A non-steroidal diene acid inhibitor of human type 2 stereoid 5α-reductase. Bioorganic and Medicinal Chemistry Letters, 4(19), 2327-2330. DOI Scopus16 WoS16
1993	Abell, A. D., Hoult, D. A., Morris, K. M., Taylor, J. M., & Trent, J. O. (1993). Halogenation of Keto Acid Phosphoranes: Synthesis of Halo Enol Lactones and Haloallenes. Journal of Organic Chemistry, 58(6), 1531-1537. DOI Scopus24 WoS24
1993	Abell, A. D., Clark, B. M., Morris, K. B., & Taylor, J. M. (1993). Fast atom bombardment mass spectra of keto acid and keto ester phosphoranes. Organic Mass Spectrometry, 28(1), 27-29. DOI
1993	Abell, A. D., & Taylor, J. M. (1993). Synthesis of Cyclic Acylated Enamino Ester Dipeptide Analogues via the Bromolactonization of a Keto Acid Phosphorane. Journal of Organic Chemistry, 58(1), 14-15. DOI Scopus28 WoS28
1993	Abell, A. D., & Litten, J. C. (1993). Synthesis and Amino Acid Chain Extension of 1-Acylated Hydroxymethylpyrroles. Australian Journal of Chemistry, 46(10), 1473-1483. DOI Scopus6 WoS7
1992	Abell, A. D., & Litten, J. C. (1992). Synthesis and hydrolysis of dipeptide isosteres containing a proline analogue with latent reactivity. Tetrahedron Letters, 33(21), 3005-3008. DOI Scopus13 WoS12
1992	Abell, A. D., Hoult, D. A., & Jamieson, E. J. (1992). Synthesis of 1,2-disubstituted pyrroles: A cis peptide bond surrogate. Tetrahedron Letters, 33(39), 5831-5832. DOI Scopus29 WoS28
1991	Abell, A. D., Trent, J. O., & Morris, K. B. (1991). Combined x-ray crystallographic and infrared and raman spectroscopic study of hydrogen bonding patterns in keto acid phosphoranes. Journal of the Chemical Society, Perkin Transactions 2, (7), 1077-1083. DOI Scopus13 WoS14
1991	Abell, A. D., Trent, J., & Robinson, W. T. (1991). Carboxy to ketone dimeric and catemeric hydrogen bonding in a keto acid phosphorane: X-ray structure of 6-ethoxycarbonyl-5-oxo-6- (triphenylphosphoranylidene)hexanoic acid. Journal of the Chemical Society, Chemical Communications, (6), 362-363. DOI Scopus18 WoS13
1991	Abell, A. D., Hartshorn, M. P., Maclennan, M. E., Robinson, W. T., & Wright, G. J. (1991). Reactions of 1,4-Dimethyl-4-nitro-cyclohexa-2,5-dien-1-yl acetates with nitrogen dioxide; The formation of polynitro cyclohexenyl esters. Australian Journal of Chemistry, 44(1), 43-51. DOI Scopus3 WoS2
1990	Abell, A. D., Morris, K. B., & McKee, V. (1990). A single-crystal x-ray analysis of a novel intramolecular hydrogen- bonded biphenyl phosphorane. Australian Journal of Chemistry, 43(4), 765-771. DOI Scopus13 WoS15
1990	Abell, A. D., Morris, K. B., & Litten, J. C. (1990). Synthesis and Deprotection of [l-(Ethoxycarbonyl)-4-[(diphenylmethoxy)carbonyl]-l-methyl-2-oxobutyl]-triphenylphosphonium Chloride: A Key Intermediate in the Wittig Reaction between a Cyclic Anhydride and a Stabilized Ylide. Journal of Organic Chemistry, 55(18), 5217-5221. DOI Scopus20 WoS17
1989	Abell, A. D., Trent, J. O., & Whittington, B. I. (1989). Low Temperature Nuclear Magnetic Resonance Study of the Acylation of a Stabilized Ylide: C- vs O-Acylation. Journal of Organic Chemistry, 54(11), 2762-2763. DOI Scopus10 WoS10
1989	ABELL, A. D., TRENT, J. O., & LITTEN, J. C. (1989). THE DESIGN AND PREPARATION OF REACTIVE AMINO-ACID ANALOGS - A NEW APPROACH TO HIV PROTEASE INHIBITION. NEW ZEALAND MEDICAL JOURNAL, 102(879), 592.
1989	Abell, A. D., & Trent, J. O. (1989). A novel bromo lactonization of acylated phosphoranes. A new route to bromo enol lactones. Journal of the Chemical Society, Chemical Communications, (7), 409-410. DOI Scopus8 WoS10
1989	Abell, A. D., Clark, B. M., & Robinson, W. T. (1989). Structural investigations of phosphoranes. a single-crystal x-ray analysis of 1-ethoxycarbonyl-2-oxopropylidene-triphenylphosphorane. Australian Journal of Chemistry, 42(7), 1161-1167. DOI Scopus21 WoS17
1989	Abell, A. D., Hartshorn, M. P., Robinson, W. T., Grant Waller, A., & Wright, G. J. (1989). Reactions of 4-methyl-1-(l′-methylethyl)-4-nitrocyclohexa-2, 5-dien-1-yl acetates with nitrogen dioxide; Towards a mechanism for the formation of polynitro cyclohexenyl esters on reaction of p-cymene with nitrogen dioxide in acetic anhydride. Australian Journal of Chemistry, 42(12), 2225-2242. DOI Scopus6 WoS4
1988	Abell, A. D., Clark, B. M., & Robinson, W. T. (1988). A Mechanistic Study of the Wittig Reaction Between a Cyclic Anhydride and a Stabilized Phosphorane. Australian Journal of Chemistry, 41(8), 1243-1249. DOI Scopus23 WoS22
1987	Schauder, J. R., Jendrezejewski, S., Abell, A., Hart, G. J., & Battersby, A. R. (1987). Stereochemistry of formation of the hydroxymethyl group of hydroxymethylbilane, the precursor of uro'gen-III. Journal of the Chemical Society, Chemical Communications, (6), 436-438. DOI Scopus15 WoS14
1985	ABELL, A. D., & MASSYWESTROPP, R. A. (1985). EREMOPHILANE AND SERRULATANE TERPENOIDS FROM EREMOPHILA-ROTUNDIFOLIA. AUSTRALIAN JOURNAL OF CHEMISTRY, 38(8), 1263-1269. DOI WoS18
1985	Abell, A. D., Heinicke, G. W., & Massy-Westropp, R. A. (1985). Synthesis of Dialkyl Hex-2-yne-1,6-dioates and Hept-2-yne-1,7-dioates. Synthesis (Germany), 1985(8), 764-766. DOI Scopus5 WoS6
1985	Abell, A. D., Horn, E., Jones, G. P., Snow, M. R., Massywestropp, R. A., & Riccio, R. (1985). The structure of a stable serrulatane diterpenoid acetal from eremophila rotundifolia. Australian Journal of Chemistry, 38(12), 1837-1845. DOI WoS10
1985	Abell, A. D., & Massywestropp, R. A. (1985). Mechanism of acetal cleavage with methylmagnesium iodide. Australian Journal of Chemistry, 38(7), 1031-1036. DOI WoS4
1985	Abell, A. D., & Massywestropp, R. A. (1985). Regioselective bond cleavage and coordination effects in the reduction of some acetals with lithium in ammonia. Tetrahedron, 41(12), 2451-2464. DOI Scopus7 WoS6
1985	Abell, A. D., Massywestropp, R. A., & Reynolds, G. D. (1985). Rearrangement of freelingyne with base. Australian Journal of Chemistry, 38(7), 1129-1131. DOI WoS2
1984	Abell, A. D., Dimitriadis, E., & Massy, R. A. W. (1984). Stereospecific formation of tetrahydrofurans from substituted 2, 8-dioxabicyclo[3.2.1]oct-3-ylmethanols. Australian Journal of Chemistry, 37(2), 395-407. DOI Scopus2 WoS3
1982	Abell, A. D., & Massy-Westropp, R. A. (1982). Aspects of the Mechanism of the Wittig Reaction Between Cyclic Anhydrides and Stabilized Phosphoranes. Australian Journal of Chemistry, 35(10), 2077-2087. DOI Scopus31 WoS31
1982	Abell, A. D., Doyle, I. R., & Massy-Westropp, R. A. (1982). The wittig reaction with glutaric and succinic anhydrides. Australian Journal of Chemistry, 35(11), 2277-2287. DOI Scopus25 WoS28

Book Chapters

Year	Citation
2020	Hudson, I. L., Leemaqz, S. Y., & Abell, A. D. (2020). Machine learning and scoring functions (SFs) for molecular drug discovery: Prediction and characterisation of druggable drugs and targets. In H. M. Cartwright (Ed.), Machine Learning in Chemistry: The Impact of Artificial Intelligence (Vol. 17, pp. 251-279). Croydon; United Kingdom: Royal Society of Chemistry. DOI
2017	Horsley, J., Yu, J., Yeoh, Y., & Abell, A. (2017). Peptides as bio-inspired molecular electronic materials. In A. Sunna, A. Care, & P. L. Berquist (Eds.), Peptides and Peptide-based Biomaterials and their Biomedical Applications (Vol. 1030, pp. 131-153). Switzerland: Springer, Cham. DOI Scopus1
2017	Abell, A. D., & Pehere, A. D. (2017). The Synthesis of Peptide-Based Macrocycles by Huisgen Cycloaddition. In E. Marsault, & M. L. Peterson (Eds.), Practical Medicinal Chemistry with Macrocycles: Design, Synthesis, and Case Studies (pp. 265-280). Hoboken, New Jersey; USA: John Wiley & Sons.
2016	Hudson, I., Leemaqz, S., Neffe, A., & Abell, A. (2016). Classifying calpain inhibitors for the treatment of cataracts: A self organising map (SOM) ANN/KM approach in drug discovery. In S. Shanmuganathan, & S. Samarasinghe (Eds.), Artificial Neural Network Modelling (Vol. 628, 1 ed., pp. 161-212). Switzerland: Springer. DOI Scopus2
2013	Abell, A., & Pehere, Ashok D.. (2013). Macrocyclic Protease Inhibitors Constrained into a β-Strand Geometry. In S. Chakraborti, & N. S. Dhalla (Eds.), Proteases in Health and Disease (pp. 181-192). Springer. DOI Scopus3
2011	Pedersen, Daniel Sejer., & Abell, A. (2011). Huisgen cycloaddition in peptidomimetic chemistry. In Hughes, Andrew B (Ed.), Amino Acids, Peptides and Proteins in Organic Chemistry, Protection Reactions, Medicinal Chemistry, Combinatorial Synthesis (Vol. 4, pp. 99-127). Wiley. DOI Scopus8
2009	Abell, A. D., & Edmonds, M. (2009). Synthesis using the Wittig and related Phosphorus-, Silicon-, or Sulfur-based reactions.. In V. H. Rawal (Ed.), Science of Synthesis (Vol. 46). Thieme Chemistry.
2004	Abell, A., & Edmonds, M. (2004). Wittig and related reactions. In P. Murphy (Ed.), Organophosphorus Reagents: A Practical Approach in Chemistry (pp. 99-126). Oxford: Oxford University Press.
2004	Edmonds, M., & Abell, A. (2004). The Wittig Reaction. In Takeshi Takeda (Ed.), Modern Carbonyl Olefination: Methods and Applications (1 ed., pp. 1-16). VCH: Wiley. DOI
1999	Abell, A. D. (1999). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Peptidomimetics and amino acid mimics (pp. 300 pages). JAI Press,.
1997	Abell, A. D. (1997). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Advances in Peptidomimetics and amino acid mimics (pp. 3002 pages). JAI Press.
1997	Abell, A. D. (1997). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Advances in Peptidomimetics and amino acid mimics (pp. 3002 pages). JAI Press.
1995	Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son).
1995	Abell, A. D. (1995). Triethyl phosphonoacetate.. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 5116-5118). John Wiley and Son.
1995	Abell, A. D., & Taylor, J. M. (1995). Trimethyl phosphonoacetate.. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 5220-5223). John Wiley and Son.
1995	Abell, A. D. (1995). Dimethyl methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2098-2110). John Wiley and Son.
1995	Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son.
1995	Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son.
1991	Abell, A. D. (1991). Latent reactivity: The study of enzyme mechanisms and the design of enzyme inactivators. In J. M. Coxon (Ed.), Advances in Detailed Reaction Mechanisms (Vol. 2, pp. 243-278). JAI Press,.

Conference Papers

Year	Citation
2021	Li, J., Capon, P. K., Horsfall, A. J., Yagoub, S., Schartner, E. P., Khalid, A., . . . Abell, A. D. (2021). Single-fiber-based probe for combined imaging and pH sensing. In Proceedings of the 2021 IEEE Photonics Conference (IPC 2021) (pp. 1-2). online: IEEE. DOI
2019	Sylvia, G. M., Schartner, E. P., McLennan, H. J., Saini, A., Dunning, K. R., Purdey, M. S., . . . Thompson, J. G. (2019). High precision pH measurements in biological environments using a portable optical fibre pH sensor. In E. M. Goldys, & B. C. Gibson (Eds.), Biophotonics Australasia 2019 Vol. 11202 (pp. 112020F-1-112020F-2). Bellingham, Washington: SPIE. DOI
2019	Hudson, I., Leemaqz, S., & Abell, A. (2019). Artificial neural networks & random forest classification of druggable molecules and disease targets via scoring functions (sfs). In 23rd International Congress on Modelling and Simulation - Supporting Evidence-Based Decision Making: The Role of Modelling and Simulation, MODSIM 2019 (pp. 28-34). online: Modelling & Simulation Society of Australia & New Zealand Inc. Scopus1
2017	Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2017). Liposome functionalization of microstructured optical fiber as ion biosensor. In Proceedings of SPIE - The International Society for Optical Engineering Vol. 10604 (pp. 42-43).
2017	Hudson, I., Leemaqz, S., Shafi, S., & Abell, A. (2017). Score function of violations and best cutpoint to identify druggable molecules and associated disease targets. In Proceedings - 22nd International Congress on Modelling and Simulation, MODSIM 2017 (pp. 487-493). online: MSSANZ. Scopus3
2016	Peddie, V., Heng, S., Mustafa, S., Thomas, J., Hutchinson, M., & Abell, A. (2016). Shapeshifting photoswitchable azobenzene compounds and their biological applications. In M. Hutchinson, & E. Goldys (Eds.), Proceedings of SPIE - The International Society for Optical Engineering Vol. 10013 (pp. 4 pages). Adelaide, AUSTRALIA: SPIE-INT SOC OPTICAL ENGINEERING. DOI
2016	Kumeria, T., Yu, J., Alsawat, M., Kurkuri, M., Santos, A., Abell, A., & Losic, D. (2016). Modulating molecular transport across peptide-modified nanoporous alumina membranes with light. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100131W-1-100131W-6). Adelaide, Australia: SPIE. DOI Scopus2 WoS2
2016	Sylvia, G., Heng, S., & Abell, A. (2016). Fluorescence enhancement of photoswitchable metal ion sensors. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100131X-1-100131X-9). Adelaide, Australia: SPIE. DOI Scopus1 WoS1
2016	Zhang, P., Ruan, S., Zhang, R., Pullen, B., Zhang, X., Purdey, M., . . . Ruan, Y. (2016). Nitric oxide sensitive optic fiber sensor based on immobilized ruthenium(II) complex. In Optics InfoBase Conference Papers Vol. Part F37-APOS 2016 (pp. 1-3). Online: OSA Publishing. DOI
2016	Purdey, M., Saini, A., McLennan, H., Pullen, B., Schartner, E., Sutton-McDowall, M., . . . Abell, A. (2016). Biosensors for detecting stress in developing embryos. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100130B-1-100130B-6). Adelaide, Australia: SPIE. DOI Scopus1 WoS1
2015	da Costa, T. P. S., Tieu, W., Abell, A. D., Polyak, S. W., & Booker, G. W. (2015). "Humanised" biotin protein ligase provides clues about inhibitor selectivity. In FEBS JOURNAL Vol. 282 (pp. 143). Berlin, GERMANY: WILEY-BLACKWELL. WoS2
2015	Purdey, M., Schartner, E., Sutton-McDowall, M., Ritter, L., Thompson, J., Monro, T., & Abell, A. (2015). Localised hydrogen peroxide sensing for reproductive health. In F. Baldini, J. Homola, & R. Lieberman (Eds.), Proceedings of SPIE, as published in Optical Sensors Vol. 9506 (pp. 950614-1-950614-10). Prague, Czech Republic: SPIE. DOI Scopus6 WoS2
2015	Purdey, M., Schartner, E., Monro, T., Aitken, R., Thompson, J., & Abell, A. (2015). Hydrogen peroxide sensing for reproductive health. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 249 (pp. 1 page). AMER CHEMICAL SOC.
2015	Pehere, A., Pietsch, M., Paul, N., Callen, D., Gutschow, M., & Abell, A. (2015). Design, synthesis, and testing of macrocyclic β-strand as protease inhibitors. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 249 (pp. 1 page). AMER CHEMICAL SOC.
2014	Neffe, A., Chua, K., Luetzow, K., Pierce, B., Lendlein, A., & Abell, A. (2014). Crosslinking of gelatin by ring opening metathesis under aqueous conditions - an exploratory study. In A. Lendlein, & M. Behl (Eds.), Polymers for Advanced Technologies Vol. 25 (pp. 1371-1375). Berlin: John Wiley & Sons. DOI Scopus3 WoS3
2014	Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2014). Functionalization of exposed core fibers with multiligand binding molecules for fluorescence based ion sensing. In J. Lopez-Higuera, J. Jones, M. Lopez-Amo, & J. Santos (Eds.), Proceedings of SPIE - The International Society for Optical Engineering Vol. 9157 (pp. 915788-1-915788-4). Santander, Spain: SPIE. DOI Scopus2 WoS1
2013	Heng, S., Nguyen, M. C., Kostecki, R., Monro, T., & Abell, A. (2013). Nanoliter-scale, regenerable ion sensor: Sensing with surface functionalized microstructured optical fiber. In Optical Sensors 2013 Vol. 8774 (pp. 29493-29504). Prague, Czech Republic: SPIE. DOI Scopus3 WoS3
2013	Zafar, S., Cheema, S., Beh, E., Hudson, I., Hudson, S., & Abell, A. (2013). Linking ordinal log-linear models with Correspondence Analysis: an application to estimating drug-likeness in the drug discovery process. In J. Piantadosi, R. Anderssen, & J. Boland (Eds.), 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013) (pp. 1945-1951). Adelaide, AUSTRALIA: MODELLING & SIMULATION SOC AUSTRALIA & NEW ZEALAND INC. Scopus7 WoS3
2009	Schartner, E., Pietsch, M., Abell, A., & Monro, T. (2009). A hydrogen peroxide fibre optic dip sensor for aqueous solutions. In Proceedings of the ACOLS ACOFT 09 Conference (pp. 61-62). CDROM: Australian Optical Society.
2008	Schartner, E. P., Monro, T. M., Ebendorff-Heidepriem, H., Pietsch, M., Abell, A. D., Hulston, C., & Davis, C. (2008). Fuel degradation sensing using microstructured optical fibres. In Materials Forum Vol. 33 (pp. 267-278).
2005	Vernall, A. J., & Abell, A. D. (2005). Cross-metathesis reactions of amino acids. In M. Flegel, M. Fridkin, C. Gilon, & J. Slaninova (Eds.), Peptides 2004, Proceedings (pp. 283-284). Prague, CZECH REPUBLIC: KENES INT.
2004	Anderson, K., Gardiner, J., & Abell, A. (2004). Conformationally constrained beta-amino acids. In Peptides 2004 : proceedings of the third international and twenty-eighth European peptide symposium (pp. 409-410). Prague, Czech Republic: KENES INT.
2003	Abell, A. (2003). Lectures presented at the 14<sup>th</sup> international conference on organic synthesis (ICOS-14), Christchurch, New Zealand, 14-18 July 2002: Preface. In Pure and Applied Chemistry Vol. 75.
2003	Gower, M. A., Le Sann, C., & Abell, A. D. (2003). Synthesis of shikimate pathway inhibitors as potential antimicrobial agents.. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 226 (pp. U64). NEW YORK, NEW YORK: AMER CHEMICAL SOC.
2000	Harvey, A. J., & Abell, A. D. (2000). Azobenzene-containing, peptidyl α-ketoesters as photobiological switches of α-chymotrypsin. In Tetrahedron Vol. 56 (pp. 9763-9771). PERGAMON-ELSEVIER SCIENCE LTD. DOI Scopus66 WoS62

Conference Items

Year	Citation
2018	Pei, J. V., Heng, S., De Ieso, M., Sylvia, G., Kourghi, M., Abell, A. D., & Yool, A. J. (2018). Real-Time Imaging of Lithium 'Hot-Spots': An Analysis of Ion Conductance in Aquaporin-1 using Novel Photo-Switchable Sensor. Poster session presented at the meeting of BIOPHYSICAL JOURNAL. San Francisco, CA: CELL PRESS.
2015	Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2015). Thin-Film Polymer Functionalization of Optical Fiber Enabling Multiligand Chemosensing. Poster session presented at the meeting of The Materials in Society Lecture Series. Singapore.
2012	Keeling, K., Abell, A., Wegner, K., Booker, G., Scanlon, D., & Martin, L. (2012). Targeting protein-protein interactions using small peptides for treatment of disease. Poster session presented at the meeting of JOURNAL OF PEPTIDE SCIENCE. WILEY-BLACKWELL.

Original Creative Works

Year	Citation
2018	Authors: Wegener K, Mcgrath A, Dixon N, Oakley A, Scanlon D, Abell A, Bruning J. Title: Rational Design of a 310-Helical PIP-Box Mimetic Targeting PCNA, the Human Sliding Clamp [Cover Profile]. Description: N/A. Extent: N/A. DOI

Patents

Year	Citation
2015	Wallace, J., Morona, R., Polyak, S., Booker, G., Abell, A., & Wilce, M. (2015). 9108978, Novel Antimicrobial Compounds. United States of America.
2006	Abell, A., Neffe, A., Stuart, B., Lee, H., Morton, J., Coxon, J., . . . Aitken, S. (2006). 550631, Compounds and compositions. New Zealand.
2006	Abell, A., Neffe, A., Stuart, B., Lee, H., Morton, J., Coxon, J., . . . Aitken, S. (2006). 547303, Calpain inhibitors and compositions. New Zealand.
1995	Abell, A. D. (1995). PCT/US95/04599, Diazo-phenanthrenone-based inhibitors of steroid 5-alpha reductase. Abell, A.D., Holt, D.A. International Application No. PCT/US95/04599, 1995..

Theses

Year Citation
2018 Schumann, N. C. (2018). Inhibition of Serine and Cysteine Proteases by Peptidomimemtic Inhibitors. (Master's Thesis, University of Adelaide).

Year	Citation
2018	Schumann, N. C. (2018). Inhibition of Serine and Cysteine Proteases by Peptidomimemtic Inhibitors. (Master's Thesis, University of Adelaide).

Major recent research grants and funding

1993-1997: PGSF funding, Synthetic and Natural Products as a Source of Pharmaceuticals ($910,000).
1996-1998: Three year funding in the inaugural round of the NZ Marsden fund ($59,000).
1998: The Agriculture and Marketing Research and Development Trust (AGMARDT) funding (PhD fellowship).
1998: Two year FORST postdoctoral funding ($140,000).
1998: Royal Society of Chemistry International Authors Travel Grant.
1999-2002: Chief Investigator A, Royal Society of NZ Marsden award. Molecular Switches and the Modulation of Chemical Reactivity and Enzyme Action ($323,000).
1999: University of Canterbury Research Grant, The Design and Synthesis of HIV Protease Inhibitors ($28,020).
2001-2003: Chief Investigator A, Royal Society of NZ Marsden award. Design and Synthesis of Shikimate Pathway Inhibitors ($475,000).
2002-2007: Chief Investigator A, FiRST grant. A medical treatment for Cataracts ($2 million over 5 years)
2003-2005: Chief Investigator A, Royal Society of NZ Marsden award. Conformationally constrained and immobilised bioactives ($600,000).
2004-2006: Chief Investigator B, Royal Society of NZ Marsden award. Behaviour, attachment and detachment of algal propagules in turbulent conditions ($700,000).
2006 –2008: Chief Investigator A, Royal Society of NZ Marsden award. ‘To beta or not to beta that is the question’ ($850,000)

Relocated to the University of Adelaide (April 2007)

2007 – 2009: Chief Investigator A, ARC Discovery grant DP077190. Mimicking peptide structure - towards an aqueous environment (A$300,000).
2008 - 2009: Chief Investigator A, ARC International Fellowship grant LX0881950. Conformationally constrained and immobilized beta-peptides (A$119,000).
2008 - 2010: Chief Investigator A, ARC Linkage International grant LX0881949. The synthesis and applications of aqueous metathesis. (A$38,000 over 3 years).
2009: Chief Investigator, ARC Lief grant LE0989336. South Australian Facility for Small and Large Molecule X-ray Diffraction Structure Determination (A$560,000)
2008 - 2009: Chief Investigator, Commercial Accelerator Scheme funding (A$250,000)
2009 - 2010: Chief Investigator NHMRC development grant. Proof of concept studies on a novel antibiotic. (A$195,000).
2009 – 2012: Chief Investigator A, ARC Discovery grant DP0985176. Electron transfer in proteins, a study of mechanism and function. (A$350,000).
2010: Chief Investigator, Cancer Council SA. Restoration of p53 activity in tumours: A new approach involving the p53 coactivator. (A$90,000).
2010: Chief Investigator, Cancer Council SA. Antagonists of Gankyrin as anti-cancer agents. (A$84,000)
2010: A lead academic for Australian Government HEEF funding to establish a centre for Photonics and Surface Science University of Adelaide (A$28.8 million).
2010-2011: Chief Investigator, International Science Linkages (ISL). Finding new medicines for important infectious diseases. (A$198,581)
2010-2013: Chief Investigator, ARC Super Science fellowship FS100100039. Disruptive approaches to biological sensing. (A$834,000)
2011: Chief Investigator, ARC Lief LE110100169. UV-VIS-IR Spectroscopic Ellipsometers for Advanced Material and Device Characterisation. (A$300,000)
2011: University of Queensland Business School Enterprize award to Calpain Therapeutics ($100,000)
2011-2014: Chief Investigator, Cancer CRC PhD top up scholarship. Proteasomal inhibitors as anti-cancer agents. (A$30,000).
2011-2014: Chief Investigator A. NHMRC Project grant APP1011806. Inhibitors of biotin protein ligase: A new class of antibiotic targetting Staphylococcus aureus. (A$585,000)
2011-2015: Chief Investigator, ARC Linkage LP110200736. Nanosampling sensors for real‑time embryo monitoring (A$420,000)
2012-2016: Chief Investigator A, ARC DP. Defining peptide structure and function: The shape of things to come (A$355,000).
2013-2017: Chief Investigator A, ARC DP130101827. Advancing New Pharmaceuticals (A$360,000)
2013: Chief Investigator A, ARC Lief LE130100168. Adelaide NMR Centre (A$1.250 million)
2014-2017 Chief Investigator A. NHMRC Project grant APP106885. A new class of antibiotic (A$725,000)
2014-2017 Chief Investigator. NHMRC Project grant APP106885. The mechanism of cataract and its prevention. (A$688,000)
2014-2021: Chief Investigator, ARC CE140100003. ARC Centre of Excellence for Nanoscale BioPhotonics. (A$40,000,000)
2016: University of Adelaide Beacon Research equipment grant ($100,000)
2017: Chief Investigator, Channel 7 Research Foundation. Designed Antibiotics Targeting Drug-Resistant and Latent Tuberculosis (181614) ($75,000)
2017: Chief Investigator in collaboration with SAHMRI. Faculty of Health and Medical Sciences Research Committee Project Development Grant. Novel tools for imaging intestinal inflammation in-vivo ($30,000)
2017: A. D. Abell. University of Adelaide Priority Partner travel grant
2017: R. Kostecki, J. Thompson, A. D. Abell, H. Ebendorff-Heidepriem. University of Adelaide Commercial Accelerator Grant. Clinical Device for Measuring Fertilisation Success during IVF treatment ($30,000)
2018-: Chief Investigator A, ARC DP180101581. Bio-Inspired Molecular Electronics: From Nanoscience to Nanotechnology (A$415,000)
2018-: Chief Investigator. Premiers Research and Industry Fund Research Consortia Program. Research Consortium Program for Agricultural Product Development ($5 million).
2021-. Australian Research Council (ARC) Linkage Infrastructure. Abell (CIA). Revitalizing Facilities for Nuclear Magnetic Resonance in South Australia. ($2,450,000)
2021. University of Adelaide Commercial Accelerator Grant. Abell (CI) 2021. Development of Pathalogy Activated Drugs for Treatment of Neuropathic Pain ($20,000)
2023 Heart Foundation, with C. Bursill (SAHMRI). Plaque-targeted Nrf2 activation using a novel switchable fumarate drug to prevent atherosclerosis ($150,000)
DIGI FAME Strategy Grant. Verjans, Abell (CI), Liao. Accelerating Drug Discovery with Machine Learning ($20,000)
2022-26: NIH Grant (USA). Development of Pathology-activated Drugs for Treatment of Neuropathic Pain. USA $8 million

TEACHING AND CURRICULUM DEVELOPMENT: UNDERGRADUATE

I have a proven ability to teach at all levels across the disciplines of chemistry and biochemistry, having done so at the Universities of Canterbury and Adelaide. I gained considerable experience in the development of new curricula and initiatives as the Head of Biochemistry at the University of Canterbury and also the Head of School of Chemistry and Physics and Chemistry Honours Coordinator at Adelaide as detailed earlier. During my tenure at Canterbury, the discipline of biochemistry grew and evolved significantly, with a number of new courses and initiatives. The end result was a highly successful and extended range of lecture and practical courses, with many students subsequently filtering into postgraduate study. During my time at the University of Canterbury, we also developed new courses on Biological and Pharmaceutical Chemistry and new stand-alone laboratory courses at 2^nd and 3^rd year. This was a somewhat radical, but ultimately highly successful initiative. More recently as Head of School of Chemistry and Physics and also Chemistry Honours Coordinator at Adelaide I have led the development and evolution of the School’s extended teaching programs in Biological and Medicinal Chemistry and also our Honours and Masters programs.

TEACHING AND SUPERVISION: POSTGRADUATE

I first became aware of the significant opportunities that tertiary education provides while visiting the University of Adelaide during my final year of high school. Prior to this I was unaware that universities existed. I have kept this sense of infinite possibility and opportunity throughout my subsequent career, with a profound desire to share my excitement with as wider an audience as possible. I am motivated to make a difference as an educator, with a passion to engage and inspire students to pursue postgraduate research studies and support strong outcomes. My passion in fostering education is also evident through formal mentoring of early career researchers (ECRs) in Chemistry, Physics, Biochemistry, Engineering, Medical Science, Law and elsewhere. This has resulted in the personal growth of ECR postgraduate practice and more specifically, supportive joint supervision of PhD students across faculties and the wider university and beyond.

My influence at the postgraduate level is considerable and international, having >250 successful postgraduate, research honours, masters, and postdoctoral fellow supervisions (including >80 PhD students) in the last 25 years, with a number of PhD students receiving local, national and international awards as detailed below. This includes jointly supervised PhD students across international institutions, most recently the Universities of Strasbourg, Copenhagen, Tokyo, Cambridge, Canterbury and Lincoln. In the last 5 years alone, I have supervised >30 PhD, 8 Masters, 15 honours students and 25 postdoctoral fellows and I currently hold mentor supervisory status. I enjoy PhD supervisory roles nationally, with joint students from the University of South Australia and the University of Newcastle. PhD graduates from my research group have gone onto occupy influential postdoctoral and commercial positions around the globe in the UK, Ireland, Germany, USA, New Zealand, Japan, Switzerland, Belgium, Singapore, Sweden, Denmark, South Africa, Australia and elsewhere. I always provide strong pastoral support and am proud to say that I have only had a couple of students not complete their studies, all because of health-related issues.

The research activities of my research group are extensive and diverse, with a large collaborative base that spans a range of disciplines with formal supervisions in chemistry, biochemistry, pharmacology, physics, photonics, health sciences, chemical engineering and statistics. This is exemplified by my key role as Adelaide node director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) which provides a world-class environment and uniquely trans-disciplinary experience for contemporary postgraduate study and career progression. It also facilitates the development and implementation of key policy and opportunity across an extended postgraduate student base. This multidisciplinary environment and educational opportunity, is greatly enhanced through commercialisation activity and interest within the CNBP, the Institute for Photonics and Advanced Sensing (IPAS) and also recently with and ImmunoLogic (USA), and Calpain Therapeutics, a privately-funded biotechnology company that I co-founded in 2011. I am proud of having established an environment that has resulted in my postgraduate students publishing high impact papers and receiving local, national and international accolades, awards and opportunities as discussed further below.

I am intimately involved in local, national and international initiatives to foster and develop post-graduate supervisor practice and initiatives. This is particularly evident as an Australian Fulbright ambassador, a prestigious national appointment and also as lead CI within the CNBP as discussed in more detail below.

SUPERVISORY PRACTICES THAT SUPPORT OUTSTANDING STUDENT OUTCOMES

Innovative Culture - Multidisciplinary research is a hallmark and central component of my supervisory practice and this provides a highly varied and unique experience for postgraduate study; with ‘real-world’ problems, connections and opportunity. This approach and philosophy to supervision is at the forefront of contemporary science with high-quality outcomes for postgraduate students; including concrete opportunities to work on finding solutions to ‘real’ problems. I also provide a strong link into the commercialisation of research and associated career opportunities through, for example, my role with the CNBP and Calpain Therapeutics as mentioned above. As the Adelaide node director of the CNBP, we have developed a number of initiatives to facilitate high quality research outputs including (1) an annual Publications Masterclass (2018 – 2019) held across all national nodes where students bring their working publications that are then developed and progressed individually and in teams; (2) personally leading the development and implementation of new approach to posters presentations within the CNBP at the national and international levels; (3) supporting postgraduates to work with national and international collaborators through visits and video link ups. In fact, we now run a weekly collaborative meeting that brings together all from across the national and international base of the centre. New students were supported to visit national nodes of the CNBP at the beginning of their studies to facilitate collaboration and opportunity. All this facilitates thesis outcomes and completions and overall experience. My skills and experiences in this sphere are internationally recognised, with regular requests to examine PhD theses - in the last few years I have been an external examiner of some 10 PhD theses from leading Australian, French, Singapore, and New Zealand Universities. Within this environment, I also provide considerable opportunity and mentorship to early career researchers (ECR), with consequential flow on effects to wider supervisory practices.

Empowering Excellence - I try to foster a highly supportive and productive research culture with extensive networking and collaborative (beyond Academia) opportunities that result in high-quality outputs, while opening doors for personal growth and career development. Greater than 99% of my 300 or so research publications have postgraduate co-authors and more than 75% involve extended collaboration across multiple disciplines.

Past postgraduate students and researchers have achieved considerable international success and influence in both academic and non-academic fields, in part because of their training and experiences within my group. Two postgraduate students received prestigious Alexander von Humboldt Postdoctoral Fellowships to study in Germany, with one now working in the German pharmaceutical industry.

SUPPORT FOR THE DEVELOPMENT OF STUDENTS AS INDIVIDUALS

As mentioned above, I have had a leading role in creating a unique opportunity-rich research culture and nurturing environment of international standing for postgraduate students at Adelaide, the scale and influence of which rivals many disciplines and institutional centres. I have done much through the CNBP to engage students in broader intellectual life and to develop as independent researchers with a full range of attributes. We develop and run professionally mediated personal development sessions on commercialisation, mental health and wellbeing, pitching and branding research with guest speakers. All this is also at the heart of the Fulbright program, the largest international scholarship program of its kind directed at promoting leadership and cross-cultural understanding. I develop and promote much in this space as an appointed national Fulbright ambassador through annual information presentations, workshops and as a member of the national panel that assesses and awards fellowships. This includes appointing and supporting international Fulbright visitors with meetings and gatherings. These activities culminate ever year with a gala event in the Great Hall at Parliament House in Canberra, an event at which I am always an invited guest and participant. This exposes the Fulbright awardees to high profile national and international leaders including USA ambassador and senior Federal politicians. I represent the Adelaide division at all these activities and events.

Members of my research group work along-side physicists and biologists in a highly collaborative experience of international standing. Postgraduate students are able to flourish and grow, while also developing entrepreneurial experience and ongoing employment opportunities. I remain a senior member of IPAS with formal supervision, mentoring and leadership roles. This, together with the activities of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) provides a unique mix of fundamental science and impact in what is a wonderful and varied environment for postgraduates and their intellectual and career development. Our approaches and technologies have broad applications across biosciences, agriculture and industry processes, and are being translated to the international biomedical and clinical communities. Our most recent endeavours are forging important links with defence and international industry including Biogen USA. Postgraduate students are creating deployable biodevices for use in health, disease management, but also veterinary care, agricultural and food manufacturing and industry processes with a clear emphasis on translation. Our postgraduates are involved at all levels of this endeavour through our established graduate program, and a number I work with have established commercial opportunity and start-up companies. All this creates an environment rich in intellectual freedom, development, and opportunity.

Supporting the development of transferable skills and knowledge - It is increasingly critical to provide students with opportunities to develop broader capabilities and industry experience that are relevant to other career options. Through the CNBP we mentor an extended array of postgraduate students (>75 nation-wide, with some 25 Uni Adel alone) and ECR’s, with specific programs designed to advance collaborative research and career learning. This includes workshops on grant and paper writing (e.g. CNBP publications masterclass workshop for PhD students at Deakin Uni, Oct 2018 and Adelaide Sept 2019), CNBP Entrepreneur Network "Shark Tank", literature reviews, the preparation of talks for conferences, a Mastermind Network that connects CNBP researchers to mentors, an ECR and Graduate Network to support CNBP students in their scientific and transdisciplinary discussions and collaboration, and other career ready activities. I actively encourage postgraduates (and also postdoctoral fellows) to engage with important external programs such as Science Meets Parliament and CSIRO on Prime (a pre-accelerator program run by the CSIRO to help research teams validate their research and discover real world applications, see http://cnbp.org.au/news ). All this provides a broad intellectual base for postgraduate students and their development within my immediate group, but also more widely to all in the CNBP.

Developing national and international postgraduate exchange programs: Institutional level - I have done much to forge and develop international postgraduate linkages to allow extended research student exchanges with France, Denmark, Germany, Japan, UK, China and Singapore. In 2017 I was awarded a University of Adelaide priority grant to spend 4 weeks at the University of Strasbourg as a prestigious visiting Professor.

As mentioned, I have a long association with the Fulbright programme, firstly as the recipient of a senior award to work in the USA for 12 months and most recently as an Australian Fulbright ambassador. This high-profile international position provides a wonderful and rewarding opportunity to fully embrace the ideals of the Fulbright programme. Our goals are to ‘promote extended educational and cultural exchange’ and I present workshops and seminars to promote and educate postgraduate students on associated opportunities thus presented.

I engage closely with an extended group of Australian and American students and Fellows through the Fulbright program and there is no better mechanism to encourage and help advance the life-long career and personal development of our best and brightest postgraduates and ECRs. I always make a point of celebrating the success of ‘Fulbrighters’ by attending the awardees presentations and functions locally and at the Great Hall, Parliament House, Canberra. Another key role of my ambassadorship is to help select Fulbright awardees through interviews at the local and national level, most recently in September this year where we selected two absolutely outstanding postgraduate students as South Australian Fellows and for higher national honours.

Providing national and international postgraduate exchange opportunities: Group level - I have always strongly supported and promoted postgraduate student exchanges, with members of my group spending time at other institutions in Germany (GKSS), Japan (University of Tokyo), China (Beijing Chinese Academy of Sciences), UK (Cambridge) and New Zealand (Universities of Canterbury and Lincoln) and also supporting visits from international students to my research group as discussed above. My research students also spend considerable time at international meetings and conferences and with our collaborators, particularly at the CNBP including RMIT, Macquarie University and international partners. We also host international research students on shorter exchanges, most recently from the University of Copenhagen and the University of Strasbourg, a priority partner institution for the University of Adelaide as discussed above.

Mentoring students in their career development following completion - I spend much time with postgraduate students and following their graduation as Early Career Researchers (ECRs), to help develop grant and fellowship applications, an area in which I am able to provide much experience having been on the ARC College. As a head of School of Physical Sciences, I was particularly passionate about promoting gender equality and diversity within its postgraduate community and I have always been a willing presenter to postgraduate and ECR’s at Faculty and research branch, and also led ARC panel and educational meetings. All this is enhanced through my role as an Australian Fulbright ambassador, where I actively promote and mentor national and international postgraduate and academic staff leaders through the extended activities of the Fulbright program as discussed above. This is a highly rewarding, influential, and privileged appointment and opportunity; with profound direct and indirect impact on postgraduate students with added ECR involvement.

3. CONTRIBUTIONS TO THE DEVELOPMENT OF EXCELLENT SUPERVISION PRACTICES

I have always been very much motivated by supporting and mentoring postgraduate and early career researchers (ECRs), with a goal to enhance supervisory practice and opportunity. I work closely with up and coming ECRs through my role as Adelaide Node Director CNBP and also with IPAS and while a member of University Council, to help develop supervisory skills and opportunities and this is in fact one of my real passions.

Other key outcomes have been achieved through my roles as Head of the School of Physics and Chemistry at the University of Adelaide (2014/15), ARC College of Experts (2012-14), postgraduate coordinator for the discipline of chemistry (ongoing), University Council, and perhaps most significantly through the Faculty of Science mentoring program. I was a passionate participant in the Faculty of Science ECR mentoring program since its inception, working closely to specifically help develop their career prospects, including supervisory practice and opportunity.

I am highly involved at the Faculty and University levels to support postgraduate initiatives and opportunities. For example, I have represented the CNBP, the Science Faculty and the University on visits to Vietnam and extensively through China, particularly to develop linkages around traditional Chinese Medicine. Helping to host a high-level delegation from Vietnam in 2013 sowed the seeds for this activity. I have also participated in University sanctioned visits to China to build linkages, particularly ECRs with two joining us for 6 months. As part of the University of Adelaide delegation in Vietnam (2015), to engage leading schools and institutions, I undertook an extended series of presentations and engagements with the best and brightest students and teachers. The Chinese work culminated with three ECRs visiting our laboratory, each for 6 months. They receive exposure to world-class multidisciplinary research as well as gain experience in postgraduate supervision and ECR development. Our visitors also provide reciprocal opportunities for our postgraduate students and ECR's.

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2024	Principal Supervisor	New practical applications for an old peptide antibiotic.	Doctor of Philosophy	Doctorate	Full Time	Mr Yifei Wang
2023	Principal Supervisor	The Design and Synthesis of New Antimicrobial Agents Based on Biotin Biology	Doctor of Philosophy	Doctorate	Full Time	Ms Taylah Renee Cruse
2023	Co-Supervisor	Rational Design and Advanced Engineering of High-Quality Nanoporous Photonic Crystal Structures	Doctor of Philosophy	Doctorate	Full Time	Mr Jairo Alberto Baron Jaimez
2023	Principal Supervisor	The development of radiopharmaceutical therapies using lead-212	Doctor of Philosophy	Doctorate	Full Time	Mr Jarred Michael Scaffidi-Muta
2023	Principal Supervisor	The development of peptide-based prodrugs for the treatment of disease.	Doctor of Philosophy	Doctorate	Full Time	Mr John Trevor Kalyvas
2022	Co-Supervisor	Bioinspired Engineering of Iontronic Membranes for Osmotic Energy Generation	Doctor of Philosophy	Doctorate	Full Time	Miss Khanh Nhien Vu
2022	Co-Supervisor	Engineering of light-matter interactions in semiconductor structures for photocatalysis	Doctor of Philosophy	Doctorate	Full Time	Mr Van Truc Ngo
2022	Co-Supervisor	Engineering of light–matter interactions in hybrid plasmonic–photonic crystal structures	Doctor of Philosophy	Doctorate	Full Time	Miss Nguyen Que Huong Tran
2021	Co-Supervisor	Harnessing Light–Matter Interactions in Nanoporous Photonic Crystal Structures for Gas Sensing	Doctor of Philosophy	Doctorate	Full Time	Mr Khoa Tran
2020	Principal Supervisor	Development of neuropathic pain therapeutics	Doctor of Philosophy	Doctorate	Full Time	Mr Dion Joel Lammas Turner
2020	Co-Supervisor	Rational Design and Advanced Engineering of High-Quality light-Emitting Nanoporous Photonic Crystal Structures	Doctor of Philosophy	Doctorate	Full Time	Mr Satyathiran Gunenthiran
2020	Co-Supervisor	Engineering of Nanoporous Platform Materials for Sensing Applications	Doctor of Philosophy	Doctorate	Full Time	Miss Juan Wang
2017	Principal Supervisor	Spiropyran-Based Photoswitchable Protease Inhibitors	Doctor of Philosophy	Doctorate	Part Time	Miss Kathryn Angela Palasis

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2020 - 2024	Co-Supervisor	Insights into Peptidomimetic Approaches for Inhibiting the DNA Sliding Clamps	Doctor of Philosophy	Doctorate	Full Time	Miss Bethiney Chantel Vandborg
2019 - 2021	Principal Supervisor	Targeting PCNA with Cell and Nuclear Permeable p21- derived Peptides	Master of Philosophy	Master	Full Time	Miss Theresa Chav
2019 - 2023	Principal Supervisor	The Design, Synthesis and Evaluation of a New Class of Antibiotic	Doctor of Philosophy	Doctorate	Full Time	Dr Damian Stachura
2018 - 2020	Principal Supervisor	Probing a Promiscuous Binding Pocket of the Proteasome	Master of Philosophy	Master	Full Time	Mr Dion Joel Lammas Turner
2018 - 2022	Principal Supervisor	Proteins as Therapeutic Targets in Ovulation, Cancer and Antibiotic Resistance	Doctor of Philosophy	Doctorate	Full Time	Mr Rouven Becker
2018 - 2023	Principal Supervisor	Small Molecules Targeting Novel Mycobacterium tuberculosis Drug Targets	Doctor of Philosophy	Doctorate	Full Time	Mr Nicholas Charles Schumann
2017 - 2021	Co-Supervisor	Progress towards the Biomimetic Total Synthesis of Meroterpenoid Natural Products	Doctor of Philosophy	Doctorate	Full Time	Ms Stefania Sassnink
2017 - 2021	Principal Supervisor	Approaches to study protein interactions	Doctor of Philosophy	Doctorate	Full Time	Miss Aimee Jade Horsfall
2017 - 2021	Co-Supervisor	Synthetic, Biomimetic and Chemoenzymatic Studies of Meroterpenoid Natural Products	Doctor of Philosophy	Doctorate	Full Time	Miss Lauren Ashleigh Marie Murray
2017 - 2020	Co-Supervisor	Advanced Photonic Crystals for Efficient Light-Trapping in Photocatalytic Applications	Doctor of Philosophy	Doctorate	Full Time	Miss Siew Yee Lim
2017 - 2021	Principal Supervisor	Fluorescent sensor development through surface functionalisation	Doctor of Philosophy	Doctorate	Full Time	Mr Patrick Keith Capon
2017 - 2020	Principal Supervisor	Towards Synthesis of a Novel Chelator for Zirconium-89	Master of Philosophy	Master	Full Time	Mr Padraig Lorcan Fyfe
2017 - 2021	Co-Supervisor	Mass Spectrometric Methods for the Analysis of Chemically Modified Proteins	Doctor of Philosophy	Doctorate	Full Time	Miss Katherine Stevens
2017 - 2020	Principal Supervisor	Controlling Peptide Structure and Function	Doctor of Philosophy	Doctorate	Full Time	Miss Yuan Qi Yeoh
2016 - 2019	Co-Supervisor	Advanced Engineering of Nanoporous Anodic Alumina Photonic Crystals for Optical Sensing Applications	Doctor of Philosophy	Doctorate	Full Time	Dr Cheryl Suwen Law
2016 - 2021	Co-Supervisor	MASS SPECTROMETRY-BASED STRUCTURAL INSIGHTS INTO PROTEIN ASSEMBLIES	Doctor of Philosophy	Doctorate	Part Time	Mr Henry Michael Sanders
2016 - 2018	Co-Supervisor	Harnessing P450 Enzymes as Biocatalysts for Selective C-H Bond Hydroxylation	Master of Philosophy	Master	Full Time	Dr Joel Hoong Zhang Lee
2016 - 2018	Principal Supervisor	Inhibition of Serine and Cysteine Proteases by Peptidomimetic Inhibitors	Master of Philosophy	Master	Full Time	Mr Nicholas Charles Schumann
2015 - 2019	Principal Supervisor	Development of New Antibiotics Based on Biotin Biology	Doctor of Philosophy	Doctorate	Full Time	Mr Kwang Jun Lee
2015 - 2017	Principal Supervisor	The Synthesis of Bimane Constrained Peptides and their Fluorescent and Structural Properties	Master of Philosophy	Master	Full Time	Miss Aimee Jade Horsfall
2014 - 2016	Principal Supervisor	Utilising CYP199A4 from Rhodopseudomonas Palustris HaA2 for Biocatalysis and Mechanistic Studies	Master of Philosophy	Master	Full Time	Miss Rebecca Chao
2014 - 2019	Principal Supervisor	Investigations into the Divergent, Biogenically Inspired Synthesis of Structurally Related Natural Products	Doctor of Philosophy	Doctorate	Full Time	Adrian Webster Markwell-Heys
2014 - 2017	Co-Supervisor	Biomimetic Total Synthesis of Natural Products	Doctor of Philosophy	Doctorate	Full Time	Mr Hiu Chun Lam
2014 - 2017	Co-Supervisor	Design and Synthesis of Protein Chemical Crosslinkers: A Modular Approach	Master of Philosophy	Master	Full Time	Miss Kayla Monique Downey
2014 - 2018	Principal Supervisor	Sensing in Biological Systems	Doctor of Philosophy	Doctorate	Full Time	Dr Georgina Maree Sylvia
2014 - 2017	Co-Supervisor	Targeted Therapies for the Treatment of Solid Cancers	Doctor of Philosophy	Doctorate	Full Time	Dr Alaknanda Emery
2013 - 2017	Co-Supervisor	Development of Biotin Protein Ligase Inhibitors as New Antibiotics to Treat Staphylococcus aureus	Doctor of Philosophy	Doctorate	Full Time	Miss Ashleigh Susan Paparella
2013 - 2017	Co-Supervisor	In Vitro and In Vivo Characterization of Staphylococcus Aureus Biotin Protein Ligase Transcriptional Repressor Function	Doctor of Philosophy	Doctorate	Full Time	Miss Jiulia Nurannisa Satiaputra
2012 - 2016	Principal Supervisor	Hydrogen Peroxide Sensing for Reproductive Health	Doctor of Philosophy	Doctorate	Full Time	Dr Malcolm Stuart Purdey
2012 - 2016	Principal Supervisor	Biomimetic Synthesis of Natural Products via Reactions of Ortho-Quinone Methides	Doctor of Philosophy	Doctorate	Full Time	Justin Thomas James Spence
2012 - 2016	Principal Supervisor	Biomimetic Synthesis of Meroterpenoid Natural Products Using Dearomatization Strategies	Doctor of Philosophy	Doctorate	Full Time	Henry Patrick Pepper
2012 - 2016	Principal Supervisor	Development of Biotin Protein Ligase Inhibitors from Staphylococcus Aureus as New Antibiotics	Doctor of Philosophy	Doctorate	Full Time	Mr Jiage Feng
2011 - 2018	Principal Supervisor	A Study on Side Chain Linked Peptides, Toward the Development of Talin Inhibitors using B3 Integrin Peptide Analogues	Doctor of Philosophy	Doctorate	Part Time	Miss Kelly Lee Keeling
2011 - 2015	Principal Supervisor	PEPTIDOMIMETIC PROTEASE INHIBITORS: ACTIVITY AND MECHANISM OF INHIBITION	Doctor of Philosophy	Doctorate	Part Time	Dr Xiao Zhou Zhang
2011 - 2017	Principal Supervisor	Photoswitchable Sensors: Reversible Ion Detection using Optical Fibres	Doctor of Philosophy	Doctorate	Full Time	Mr Daniel Brian Stubing
2011 - 2015	Principal Supervisor	The Effects of Macrocyclic Constraints on Electron Transfer in Peptides	Doctor of Philosophy	Doctorate	Full Time	Dr John Robert Horsley
2009 - 2014	Principal Supervisor	A study on the interactions of synthetic IGF-II analogues with the type 1 IGF and insulin receptors	Doctor of Philosophy	Doctorate	Part Time	Miss Jade Misty Cottam
2009 - 2013	Co-Supervisor	Exploring the Structure-Function Relationship of Biotin Protein Ligase from Staphylococcus aureus: Implications for Selective Inhibitor Design	Doctor of Philosophy	Doctorate	Full Time	Dr Tatiana Soares da Costa
2008 - 2013	Principal Supervisor	Design, synthesis and testing of conformationally constrained peptidomimetics	Doctor of Philosophy	Doctorate	Part Time	Miss Joanna Duncan
2008 - 2011	Principal Supervisor	ß-Strand Mimicry as the Basis for a Universal Approach to Protease Inhibition	Doctor of Philosophy	Doctorate	Full Time	Mr Seth Adam Jones
2008 - 2012	Principal Supervisor	New Peptide based Templates Constrained into a Beta-Strand by Huisgen Cycloaddition	Doctor of Philosophy	Doctorate	Full Time	Mr Ashok Dattatray Pehere
2008 - 2013	Principal Supervisor	Defining Peptide Structure with Metathesis	Doctor of Philosophy	Doctorate	Full Time	Ms Krystle Chua
2007 - 2012	Principal Supervisor	Design and Synthesis of Reaction Intermediate Derivatives as Biotin Protein Ligase Inhibitors	Doctor of Philosophy	Doctorate	Full Time	Dr William Tieu
2006 - 2010	Co-Supervisor	Synthesis of Glutamate Mimics as Neuropathic Pain Modulating Agents	Doctor of Philosophy	Doctorate	Full Time	Dr Nathan Stanley

Other Supervision Activities

Date	Role	Research Topic	Location	Program	Supervision Type	Student Load	Student Name
2023 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Master	-	Yifei John Wang
2023 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Honours	-	Bide Di
2022 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Master	-	John Trevor Kalyvas
2022 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Master	-	Jarred Michael Scaffidi-Muta
2022 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Postdoctorate	-	Dr Damian Stachura
2018 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Thomas Avery
2018 - 2018	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Kate Wegener
2018 - 2018	External Supervisor	Biological Chemistry	University of Copenhagen	-	Master	Full Time	Dounia Krouch
2018 - 2018	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Bianca Jong
2018 - 2018	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Damian Stachura
2017 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Thomas Almond
2016 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Malcolm Purdey
2016 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Niels Krogsgaard-Larsen
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Yuan Qi Yeoh
2016 - 2016	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Master	Full Time	Joel Lee
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Kathryn Palasis
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Lauren Murray
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Amanpreet Chahal
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Lina Geng
2016 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Stephen Kirby
2015 - ongoing	Principal Supervisor	Chemistry	The University of Adelaide	-	Postdoctorate	-	Dr John Horsley
2015 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Aniket Kulkarni
2015 - 2015	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Irene Willcocks
2015 - 2015	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Vincent Donohue
2015 - 2015	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Ashok Pehere
2015 - 2015	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Nathan Stanley
2014 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Beatriz Blanco Rodríguez
2014 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Michelle Zhang
2014 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Borja Lopez
2014 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Victoria Peddie
2014 - 2016	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Part Time	Dr Kelly Keeling
2014 - 2014	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Sarah Clark
2014 - 2014	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Master	Full Time	Stephen Tulip
2014 - 2014	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr John Horsley
2014 - 2014	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Jenny Butler
2013 - 2013	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Benjamin Keiller
2013 - 2013	External Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	David Armstrong
2013 - 2013	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Alexandra Marrone
2012 - 2013	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Ondrej Zvarec
2012 - 2012	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Ross Tieman
2012 - 2012	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Malcolm Purdey
2012 - 2012	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Tim Engler
2012 - 2012	Co-Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Angie Jarrad
2011 - 2014	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr William Tieu
2011 - 2011	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Xiaozhou (Michelle) Zhang
2010 - 2010	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Daniel Stubing
2010 - 2010	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Jiage Feng
2009 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Jingxian Yu
2009 - 2017	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Sabrina Heng
2009 - 2009	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Kelly Keeling
2009 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Denis Scanlon
2008 - 2009	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr James Gardiner
2008 - ongoing	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Steven Polyak
2008 - 2008	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Kevin Kuan
2008 - 2008	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Honours	Full Time	Kim Mitchel
2007 - 2018	Principal Supervisor	Biochemistry	The University of Adelaide	-	Postdoctorate	-	Steven Polyak
2007 - 2012	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Joanna Duncan
2007 - 2011	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Hongyuan Chen
2007 - 2010	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Blair Stuart
2007 - 2009	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Shazia Zaman
2007 - 2009	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Steven Ballet
2007 - 2008	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Daniel Sejer Pedersen
2007 - 2008	Principal Supervisor	Biological Chemistry	University of Adelaide	-	Postdoctorate	Full Time	Dr Markus Pietsch
2007 - 2008	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Tarek Millar
2006 - 2010	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Victoria Peddie
2006 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Andrew Muscroft-Taylor
2006 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Blair Stuart
2006 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Shigeru Miyamoto
2006 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Victoria Peddie
2006 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Joanna Duncan
2005 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Nathan Alexander
2005 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Kelly Anderson
2005 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	David Pearson
2005 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Wilford Lie
2005 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Mutita Klanchantra
2005 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Hongyuan Chen
2005 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Aimee Zhang
2004 - 2008	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Matt Jones
2004 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Janna Nikkel
2004 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Mary Gower
2004 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Anna McCarthy
2004 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Nathan Alexander
2004 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Stephen McNabb
2004 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Tom Cain
2004 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Kelly Anderson
2004 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Seth Jones
2004 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	David Pearson
2003 - 2007	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Paula Brooksby
2003 - 2006	Co-Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Hannah Lee
2003 - 2006	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Steve Aitken
2003 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Andrea Vernall
2003 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Christine Le Sann
2003 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Barbara Thompson
2003 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Axel Neffe
2003 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Barbara Thompson
2003 - 2003	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Anna McCarthy
2003 - 2003	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Emma Turner
2003 - 2003	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Jennifer Gadd
2002 - 2005	External Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Richard Payne
2002 - 2005	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Shazia Zaman
2002 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Florian Graichen
2002 - 2004	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Karina Brown
2002 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Andrea Vernall
2002 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Matt Rosenberg
2002 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Mary Gower
2002 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Janna Nikkel
2002 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Andrea Vernall
2001 - 2001	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Richard Payne
2001 - 2001	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Hayden Peacock
2000 - 2003	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Derek Martyn
2000 - 2003	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	James Gardiner
2000 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Kelly Smith
2000 - 2002	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Emma Turner
2000 - 2001	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Kristian Giles
2000 - 2000	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Jenny Malmström
2000 - 2000	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Karina Brown
1999 - 2001	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Mark Humphries
1999 - 2001	Co-Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Scott Bringans
1999 - 2001	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Alison Daines
1999 - 2000	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Tim May
1999 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Kelly Smith
1999 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Derek Martyn
1999 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	James Gardiner
1998 - 2001	Co-Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Kristian Giles
1998 - 2000	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Andrew Harvey
1998 - 2000	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Barnaby May
1998 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Dr Michael Edmonds
1998 - 1998	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Alison Daines
1997 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Brent Nabbs
1997 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Andy Phillips
1997 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Maureen Price (Ratcliff)
1997 - 1997	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Elizabeth Reid
1997 - 1997	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Seung-Joo Lee
1996 - 1999	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Elizabeth Reid
1996 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Barnaby May
1996 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Andrew Harvey
1996 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Maureen Price (Ratcliff)
1996 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Andy Phillips
1995 - 1998	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Michael Moore
1995 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Sangeeta Budia
1995 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Fiona Buchanan
1995 - 1995	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Brent Nabbs
1995 - 1995	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	James Murphy
1995 - 1995	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Blair Henderson
1994 - 1997	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Mark Oldham
1994 - 1994	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Michael Moore
1993 - 1997	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Deborah Hoult
1993 - 1996	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Glenn Foulds
1993 - 1993	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Mark Oldham
1992 - 1992	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Deborah Hoult
1992 - 1992	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Glenn Foulds
1990 - 1992	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	John Trent
1990 - 1992	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Doctorate	Full Time	Chris Litten
1990 - 1990	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Jane Taylor
1989 - 1989	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Chris Litten
1988 - 1989	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Master	Full Time	Kathy Morris
1988 - 1988	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Honours	Full Time	Emily Jamieson
1987 - 1988	Principal Supervisor	Biological Chemistry	University of Canterbury	-	Postdoctorate	Full Time	Bruce Clark

Board Memberships

Date	Role	Board name	Institution name	Country
2022 - ongoing	Co-Founder	Scientific Officer	ImmunolLogic	United States
2015 - ongoing	-	University of Adelaide Academic Board	University of Adelaide	-
2015 - 2021	Member	University of Adelaide Academic Board	University of Adelaide	Australia
2011 - ongoing	-	Chief Scientific Advisor and co-founder of new company, Calpain Therapeutics	-	-
2011 - ongoing	-	Australian Research Council (ARC) College of Experts	-	-
2006 - ongoing	-	6th European Union Funding Framework panel (Brussels)	-	-
2005 - ongoing	-	Governing Board of NZ Chemical Genetics consortium	-	-
2005 - ongoing	-	Australasian representative to the advisory group of two PACIFICHEM symposia (Hawaii)	-	-
2005 - ongoing	-	New Zealand (MoRST) sponsored delegation to the Riken Institute Japan	-	-
2001 - ongoing	-	International representative to the Australian National Health and Medical Research Council Program Grant Committee (Melbourne Australia)	-	-
2001 - ongoing	-	Royal Society of New Zealand Marsden Physical Sciences and Engineering panel	-	-
2000 - ongoing	-	Australasian representative to the advisory group of two PACIFICHEM symposia (Hawaii)	-	-
2000 - ongoing	-	New Zealand representative to the Australian Peptide Association	-	-

Committee Memberships

Date	Role	Committee	Institution	Country
2023 - ongoing	Member	ARC advisory	Australian Research Council	Australia
2013 - 2014	Member	University of Adelaide Promotions Committee	University of Adelaide	Australia
2006 - 2007	Member	University of Canterbury Academic Board	University of Canterbury	New Zealand
2003 - 2023	Member	New Zealand Representative Australasian Peptide Conference Organising Committee	Australasian Peptide Conference	Australia
2003 - ongoing	Chair	NZIC international Conference	New Zealand Institute of Chemistry	New Zealand
2002 - 2005	Member	PACIFICHEM symposia (Hawaii)	PACIFICHEM	United States
2002 - 2003	Advisory Board Member	5th International Peptide Conference	RACI	Australia
2002 - 2003	Member	Conference Symposium Manager	14th International Conference on Organic Chemistry	New Zealand
2001 - 2002	Advisory Board Member	International Union of Pure and Applied Chemistry Conference	International Union of Pure and Applied Chemistry	United Kingdom
2001 - 2001	Advisory Board Member	Australian National Health and Medical Research Council Program Grant Committee	NHMRC	Australia
2001 - 2001	Member	National Health and Medical Research Council	NHMRC	Australia
2000 - 2001	Advisory Board Member	Pacifichem Cysteine Proteases Symposium	Pacifichem	United States
1999 - 2002	Chair	Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology	New Zealand Society for Biochemistry and Molecular Biology	New Zealand

Consulting/Advisories

Date	Institution	Department	Organisation Type	Country
2023 - ongoing	Royal Australian Chemical Institute (RACI)	Medicinal Chemistry	Business and professional	Australia
2018 - ongoing	Traditional Chinese Medicine University	TCM	Scientific research	China
2017 - ongoing	The European Federation for Medicinal Chemistry (EFMC)	Medicinal Chemistry	Business and professional	Austria
2016 - 2021	European Commission	Marie Skłodowska Curie Fellowship Panel	Business and professional	Belgium
2014 - 2014	Advanced Veterinary Therapeutics	Therapeutics	Business and professional	Australia
2013 - 2013	Minter Ellison	legal	Business and professional	Australia
2005 - 2007	Eli Lilly Pharmaceuticals (USA)	Pharmaceuticals and legal	Business and professional	United States
2005 - 2006	Eli Lilly and Company	Pharmaceuticals	Health services and related	United States
1993 - 1994	SmthKline Beecham Pharmaceuticals (USA)	Pharmaceuticals	Health services and related	United States
1993 - 1994	SmithKline Beecham Pharmaceuticals USA	Medicinal Chemistry	Health services and related	United States

Event Participation

Date	Event Name	Event Type	Institution	Country
2016 - ongoing	South Australian Teachers conference	Congress	South Australian Teachers	Australia
2001 - 2002	14th International Conference on Organic Chemistry	Convention	International Conference on Organic Chemistry	-
1998 - 2004	New Zealand Chemistry Olympiad	Plenary or general session	New Zealand Chemistry Olympiad	-

Expert Witness

Date Case Institution Country
2022 - ongoing Patent Infringement Biogen USA United States
2005 - 2006 Patent Infringement Eli Lilly Parmaceuticals (USA) Australia

Date	Case	Institution	Country
2022 - ongoing	Patent Infringement	Biogen USA	United States
2005 - 2006	Patent Infringement	Eli Lilly Parmaceuticals (USA)	Australia

Industry Partnerships

Date	Engagement Type	Partner Name
2022 - ongoing	Research Contract	Immunologic (USA)
2007 - ongoing	Consultant	Calpain Therapeutics
2005 - ongoing	Consultant	Riken Institute Japan - MoRST sponsored
1993 - ongoing	Consultant	SmithKline Beecham Fulbright USA Schools
1993 - ongoing	Consultant	Smith Kline becham (USA)

Offices Held

Date	Office Name	Institution	Country
2021 - ongoing	Chemistry Postgraduate Coordinator	The University of Adelaide	Australia
2021 - ongoing	University of Adelaide Honours Chemistry Coordinator	University of Adelaide	Australia
2016 - ongoing	Fulbright Ambassador	Fulbright	United States
2014 - ongoing	Node Director ARC Centre of excellence	CNBP University of Adelaide	Australia
2013 - 2014	Head of School of Chemistry and Physics	The University of Adelaide	Australia
2002 - ongoing	Chief Scientific Officer and Co-founder	Calpain Therapeutics	New Zealand
2002 - 2003	Conference Chair New Zealand Institute of Chemistry (NZIC) National Convention	New Zealand Institute of Chemistry (NZIC)	New Zealand
2002 - ongoing	New Zealand MacDiarmid Institute for Advanced Materials and Nanotechnology	NZ CoRE	New Zealand
2001 - 2002	Conference Editor for the International Union of Pure and Applied Chemistry	International Union of Pure and Applied Chemistry	United Kingdom
2000 - 2003	Head of Biochemistry University of Canterbury	University of Canterbury	New Zealand
2000 - 2002	University of Canterbury head of Biochemistry	University of Canterbury	New Zealand
1999 - 2002	Chairperson of the Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology	Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology	New Zealand
1990 - 1993	Canterbury chairperson	New Zealand Institute of Chemistry (NZIC)	New Zealand

Position: Professor
Phone: 83135652
Email: andrew.abell@adelaide.edu.au
Fax: 83134380
Campus: North Terrace
Building: Badger, floor G
Org Unit: Chemistry